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CHAPTER 1 - INTRODUCTION
Cardiovascular responses during dynamic exercise are a result of a complex
interaction between at least three mechanisms: central command, the arterial baroreflex
and the muscle metaboreflex. Central command primarily controls parasympathetic
activity to the heart and has little control over sympathetic nerve activity (SNA) (89).
The arterial baroreflex is a negative feedback reflex which maintains arterial pressure
primarily by modulating peripheral vascular conductance.

An increase in arterial

pressure causes baroreflex-induced peripheral vasodilation and bradycardia while a
decrease in arterial pressure evokes peripheral vasoconstriction and tachycardia,
restoring arterial pressure back to normal in both scenarios.

During exercise, the

arterial baroreflex is reset to a higher level but without any change in the gain of reflex
(20, 53, 62). The muscle metaboreflex is activated when insufficient oxygen delivery to
the exercising skeletal muscle results in accumulation of metabolites (e.g., hydrogen
ions, adenosine, diprotonated phosphate, etc.) which stimulate the group III/IV muscle
afferents eliciting a large pressor response, termed the muscle metaboreflex (1, 9, 65,
76, 77).
Muscle metaboreflex activation (MMA) during dynamic exercise causes
significant increases in mean arterial pressure (MAP), heart rate (HR), cardiac output
(CO) and ventricular contractility which along with enhanced central blood volume
mobilization maintains or slightly increases stroke volume (6, 18, 43, 70, 71, 95). With
stroke volume being maintained, the rise in HR elicits substantial increases in CO.
However, the peripheral vascular responses have varied in previous studies. While
significant vasoconstriction has been observed in the renal, coronary and forelimb
vascular beds (6, 13, 48, 49) when taken as a whole, the total vascular conductance of
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all vascular beds except the hindlimbs, termed non-ischemic vascular conductance
(NIVC), usually remains unchanged or slightly increases (6, 13, 40, 69, 78). Inasmuch
as some individual vascular beds do vasoconstrict, the observation of no change or
slight increase in NIVC indicates that some vascular bed(s) must vasodilate. What
causes this vasodilation is unknown. Metaboreflex-mediated increases in SNA can lead
to elevated pre-ganglionic sympathetic activity to the adrenal glands which can
substantially increase epinephrine release (8, 41, 44, 46) resulting in β2-mediated
vasodilation, especially in the skeletal muscle which is richly endowed with β2adrenergic receptors. In addition, post-ganglionic sympathetic nerve terminals have
also been shown to release epinephrine (8, 41, 44, 46). However, whether epinephrine
release contributes to muscle metaboreflex-induced peripheral vascular responses is
unknown.
Muscle metaboreflex is generally considered as a flow-mediated, flow-raising
reflex which is activated by insufficient blood flow and oxygen delivery to the active
skeletal muscle and raises total systemic blood flow (i.e., CO) to improve blood flow and
oxygen delivery to the ischemic vasculature.

MMA during submaximal exercise

increases MAP, HR, CO and ventricular contractility along with some regional
vasoconstriction (6, 13, 48, 49). The metaboreflex-induced increase in MAP is primarily
caused by an increase in CO, as little if any net peripheral vasoconstriction occurs (18,
32, 71, 74). Several studies have suggested that the metaboreflex-induced increase in
CO partially restores blood flow to the ischemic active skeletal muscle (16, 56, 59, 68).
Whether the increased SNA during MMA activation vasoconstricts the ischemic active
muscle from which the reflex originates is unknown. Should this occur, then the ability
of the muscle metaboreflex to correct the deficits in blood flow to the ischemic muscle
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would be restrained.
Heart failure (HF) is characterized by low CO and high SNA during rest and
exercise.

With only moderate exercise, massive sympathetic activation is often

observed in HF, resulting in an exaggerated metaboreflex activation (29). With the
normal metaboreflex-induced increases in CO being substantially attenuated in HF, the
mechanisms of metaboreflex shift from flow-mediated to vasoconstriction-mediated
pressor responses in HF (16, 29, 58). The ability of vasoconstriction in a given vascular
bed to raise MAP is directly related to the fraction of CO received by that bed. During
exercise most of the CO is directed to the active skeletal muscle. Vasoconstriction of
inactive vascular beds plays a very small role in any reflex pressor response as blood
flow to the inactive beds constitutes only a small proportion of CO and thereby, total
vascular conductance (TVC). With a large proportion of CO going to the exercising
skeletal muscle, it is this vascular bed which is the likely target vasculature for
metaboreflex-induced vasoconstriction in HF.

With exaggerated SNA in HF,

metaboreflex activation could lead to heightened vasoconstriction of active muscle,
possibly including the ischemic muscle itself.

In this case, vasoconstriction of the

already ischemic muscle would lead to further ischemia in the muscle that would
potentiate the reflex activation causing a positive feedback loop scenario. Whether
MMA in HF induces an exaggerated vasoconstriction of ischemic active muscle itself is
unknown.
Another key regulator of arterial blood pressure is the arterial baroreflex. During
dynamic exercise in normal individuals, arterial baroreflex is reset to a higher arterial
pressure although its strength to regulate pressure remains unaltered (21, 53, 62, 67).
Sheriff et. al. (72) showed that during MMA, baroreflex buffers up to 50% of the
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metaboreflex-mediated increases in MAP.

Kim et. al. (40) demonstrated that this

buffering occurs by restraining metaboreflex-induced peripheral vasoconstriction. After
sinoaortic denervation (SAD) in the same animals, metaboreflex-induced pressor
response was twice as large and resulted from a combination of peripheral
vasoconstriction and increase in CO. Thus, the arterial baroreflex alters the strength
and mechanisms of the muscle metaboreflex during dynamic exercise by inhibiting
metaboreflex-mediated peripheral vasoconstriction.

When carotid receptors are

unloaded via bilateral carotid occlusion (BCO), the substantial increase in MAP occurs
primarily due to peripheral vasoconstriction (11). Therefore, muscle metaboreflex and
arterial baroreflex have distinct mechanisms for regulating MAP and no studies have yet
investigated the interaction between the two when activated concurrently.

The

interaction of the arterial baroreflex and the muscle metaboreflex has not been well
established, especially when these reflexes are coactivated.

Furthermore, previous

studies from our laboratory have concluded that active skeletal muscle is a primary
target for baroreflex-induced peripheral vasoconstriction (11). To what extent ischemic
active muscle may vasoconstrict is controversial.
HF alters the strength of arterial baroreflex both at rest (61) and during exercise
(38). This impairment would lessen the ability of baroreflex to attenuate peripheral
vasoconstriction induced by muscle metaboreflex, leading to a larger increase in
vascular sympathetic tone compared to normal subjects. Inasmuch as the strength of
the baroreflex and baroreflex buffering of metaboreflex-induced pressor response are
impaired in HF, there would be a smaller pressor response with metaboreflex and
baroreflex coactivation. To what extent HF alters the interaction between the baroreflex
and muscle metaboreflex is unknown. Therefore, my studies are designed to address
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three tightly coupled Specific Aims.

My approach is to use a complex chronically

instrumented canine model. All studies are longitudinal in nature. The animals are
instrumented and responses are observed on different days and in different settings
(e.g. agonist/antagonist infusions, rest vs. exercise, etc.), then heart failure is induced
and the experiments are repeated in the same animals. Thus, each animal serves as its
own control.
Specific Aim (I): To determine the mechanism(s) mediating muscle metaboreflex
control of blood flow to the non-ischemic active vasculature during dynamic
exercise.
Muscle metaboreflex-induced pressor response is caused virtually solely by an
increase in cardiac output, as little, if any, increase in total vascular conductance
occurs. In several studies, we observed that muscle metaboreflex activation caused a
significant increase in vascular conductance of all vascular beds except the hindlimbs
(termed non-ischemic vascular conductance; NIVC) (6, 40, 69). I hypothesized that this
increase in NIVC may stem from a metaboreflex-induced release of epinephrine
resulting in β2-adrenergic mediated vasodilation in the skeletal muscle.
Specific Aim (II): To determine the mechanism(s) mediating muscle metaboreflex
control of blood flow to the ischemic active vasculature during submaximal
dynamic exercise in normal animals and in the same animals after induction of
heart failure.
We and others have shown that MMA elicits vasoconstriction of the coronary,
renal and forelimb vasculatures. Whether the metaboreflex vasoconstricts the ischemic
muscle from which it originates has been controversial. HF is characterized by markedly
elevated SNA both at rest and during exercise. When metaboreflex-induced increase in
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cardiac output becomes limited in HF, MMA causes large peripheral vasoconstriction.
Whether MMA in HF causes exaggerated vasoconstriction of the ischemic active
muscle is unknown.

I hypothesized that MMA elicits vasoconstriction of the active

skeletal muscle in normal subjects and this vasoconstriction is exacerbated in HF.
Specific Aim (III): To investigate the interaction between the muscle metaboreflex
and the arterial baroreflex before and after induction of heart failure.
Activation of both reflexes would cause an exaggerated pressor response, a
resultant effect of both, an increase in CO and peripheral vasoconstriction. I tested
whether the interaction between the two reflexes is additive, occlusive or facilitative.
Since carotid baroreceptor unloading induces peripheral vasoconstriction, to what
extent the ischemic muscle vasoconstricts during coactivation of the baroreflex and the
muscle metaboreflex is unknown. The strength of arterial baroreflex is impaired in HF
and coactivation of metaboreflex and baroreflex in HF would cause a smaller pressor
response compared to normal individuals.
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CHAPTER 2 - MUSCLE METABOREFLEX ACTIVATION DURING DYNAMIC
EXERCISE EVOKES EPINEPHRINE RELEASE RESULTING IN β2-MEDIATED
VASODILATION
(This Chapter contains previously published material. See Appendix B)
Abstract
Muscle metaboreflex-induced increases in mean arterial pressure (MAP) during
submaximal dynamic exercise are mediated principally by increases in cardiac output.
To what extent, if any, the peripheral vasculature contributes to this rise in MAP is
debatable. In several studies, we observed that in response to muscle metaboreflex
activation (MMA; induced by partial hindlimb ischemia) a small but significant increase
in vascular conductance occurred within the non-ischemic areas (calculated as cardiac
output minus hindlimb blood flow and termed non-ischemic vascular conductance;
NIVC). We hypothesized that these increases in NIVC may stem from a metaboreflexinduced release of epinephrine resulting in β2-mediated dilation. We measured NIVC
and arterial plasma epinephrine levels in chronically instrumented dogs during rest, mild
exercise (3.2 kph) and MMA before and after β-adrenergic blockade (propranolol; 2
mg/kg), α1-adrenergic blockade (prazosin; 50 µg/kg) and α1+β-blockade.

Both

epinephrine and NIVC increased significantly from exercise to MMA: 81.9 ± 18.6 to
141.3 ± 22.8 pg/ml and 33.8 ± 1.5 to 37.6 ± 1.6 ml/min/mmHg, respectively. These
metaboreflex-induced increases in NIVC were abolished after β-blockade (27.6 ± 1.8 to
27.5 ± 1.7 ml/min/mmHg) and potentiated after α1-blockade (36.6 ± 2.0 to 49.7 ± 2.9
ml/min/mmHg), while α1+β-blockade also abolished any vasodilation (33.7 ± 2.9 to 30.4
± 1.9 ml/min/mmHg). We conclude that MMA during mild dynamic exercise induces
epinephrine release causing β2-mediated vasodilation.
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Introduction
Insufficient oxygen delivery to active skeletal muscle during dynamic exercise
causes accumulation of metabolites (e.g., hydrogen ions, lactate, diprotonated
phosphate, etc.) which activate group III/IV chemosensitive afferents eliciting a reflex
increase in arterial blood pressure and sympathetic outflow, known as the muscle
metaboreflex (1, 9, 43, 65, 66, 75-77, 95).

The metaboreflex-mediated pressor

response during submaximal dynamic exercise occurs virtually solely via increases in
cardiac output (CO) as no net peripheral vasoconstriction occurs (18, 32, 70, 71, 74,
78).

The rise in CO is supported by substantial tachycardia, improved ventricular

contractility which along with enhanced central blood volume mobilization facilitates a
maintained or slightly elevated stroke volume (13, 16-18, 26, 69-71, 74).
Several studies have suggested that the muscle metaboreflex improves blood
flow to the ischemic working muscle (16, 56, 59, 68, 95). However, very few studies
have investigated the effect of muscle metaboreflex activation on blood flow to nonischemic active muscle and the results are equivocal.

Using the model originally

developed by Wyss et al. (95) to investigate the metaboreflex (graded reductions in
hindlimb blood flow), Mittelstadt et al. (48) showed that metaboreflex activation during
moderate exercise in canines causes forelimb (a non-ischemic active tissue)
vasoconstriction, however forelimb blood flow still increased due to the large pressor
response (the rise in arterial pressure was greater than the fall in forelimb vascular
conductance, therefore forelimb blood flow increased). In contrast, Augustyniak et al.
(5) did not find a significant decrease in forelimb conductance with metaboreflex
activation during moderate exercise.
In previous studies in normal animals, we often observed a small but statistically
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significant metaboreflex-mediated increase in the total non-ischemic systemic vascular
conductance (NIVC) (conductance to all vascular beds excluding the hindlimbs) during
submaximal dynamic exercise (6, 40, 69). In contrast, after induction of heart failure
this small vasodilation is reversed to a substantial metaboreflex-mediated peripheral
vasoconstriction due to much greater reflex increase in sympathetic activity (29).
Therefore there appears to be both vasodilator as well as vasoconstrictor processes
elicited by metaboreflex activation. Whereas many studies have shown that activation
of the muscle metaboreflex can elicit increases in sympathetic activity and peripheral
vasoconstriction (6, 29, 87), the mechanisms mediating vasodilation are unknown.
Increases in sympathetic activity to the adrenal gland increases epinephrine release
which can elicit substantial vasodilation, especially so in the skeletal muscle (8, 41, 45,
46).

However, whether epinephrine release contributes to muscle metaboreflex-

induced peripheral vascular responses is unknown. In the present study we tested the
hypothesis that during metaboreflex activation epinephrine is released and causes β2mediated peripheral vasodilation.
Methods
Experimental subjects
Eleven adult mongrel canines (~20-25 kg) of either sex were selected for the
study. All animals were acclimatized to the laboratory surroundings and willing to run
on a motor-driven treadmill. All the methods and procedures employed in the study
were approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne
State University and complied with the National Institutes of Health Guide to the Care
and Use of Laboratory Animals.

All animals

exercised

experimentation; no negative reinforcement techniques were utilized.

voluntarily

during
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Surgical procedures
For each of the two surgical procedures, the animals were sedated with
acepromazine (0.4-0.5 mg/kg IM) and received preoperative analgesics [carprofen (2.0
mg/kg IV), buprenorphine (0.01 mg/kg IM) and fentanyl (100-175 µg/h (72h) transdermal
delivery)]. Anesthesia was induced with ketamine (5.0 mg/kg IV) and diazepam (0.22
mg/kg IV) and maintained with isoflurane gas (1-3%). For postoperative care, animals
were closely monitored and given buprenorphine and acepromazine (0.05 and 0.5
mg/kg IV, respectively) as needed. To avoid acute postoperative infections, cefazolin
(antibiotic, 30 mg/kg IV) was administered pre- and postoperatively.

Cephalexin

(antibiotic, 30 mg/kg PO BID) was administered prophylactically for the entire term of
the experimental protocol.
In the first surgical procedure, the thoracic cavity was opened via a left
thoracotomy (3rd/4th intercostal space) approach and the pericardium was cut to
expose the heart. A perivascular flow probe (20PAU, Transonic Systems) was placed
around the ascending aorta to measure CO.

For studies unrelated to the present

investigation, in some animals (n=6) a telemetry blood pressure transmitter (TA11 PAD70, DSI) was placed in the left ventricle, a flow probe was placed on the left circumflex
artery (n=5) and pacing wires were secured to the free wall of the right ventricle (n=6)
as described previously (29). The pericardium was reapproximated, the wires were
tunneled subcutaneously and exteriorized between the scapulae. The chest was closed
in layers.
In the second surgical procedure, an incision was made on the left flank cranial
to the iliac crest to expose the abdominal aorta and left renal artery. A perivascular flow
probe (10PAU, Transonic Systems) was positioned around the terminal aorta to
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measure hindlimb blood flow (HLBF). For studies unrelated to the present investigation,
a blood flow transducer was also placed on the left renal artery. All side branches of the
terminal aorta between the iliac arteries and the aortic flow probe were ligated and
severed. Two hydraulic occluders (8-10 mm, DocXS Biomedical Products) were placed
around the terminal aorta just distal to flow probe and, for unrelated studies, a hydraulic
occluder was also placed on the left renal artery. A 19-gauge polyvinyl catheter (Tygon,
S54-HL, Norton) was inserted into a side branch of the aorta cranial to the flow probe to
measure systemic arterial pressure. All instrumentation was tunneled subcutaneously
and exteriorized between the scapulae and the abdomen was closed in layers. Lastly,
in some animals (n=6), a midline neck incision was made to expose and catheterize the
right jugular vein for unrelated studies.
Data acquisition
Each animal was brought into the laboratory and allowed to roam freely and
acclimate for ~10-20 minutes, following which it was directed onto the treadmill. The
flow probe cables were connected to flow meters (TS420, Transonic Systems). The
arterial catheter was aspirated, flushed and connected to a pressure transducer
(Transpac IV, ICU Medical). All hemodynamic variables were monitored as real-time
waveforms by a data acquisition system (LabScribe, iWorx) and recorded for
subsequent off-line analysis.
Experimental procedures
All experiments were performed after the animals had fully recovered from
surgery (i.e., were active, afebrile and of good appetite). Each experiment began with
the animal standing still on the treadmill until all resting hemodynamic data were stable
(typically 5-10 min).

The treadmill was turned on and the speed was gradually
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increased to 3.2 kph at 0% grade. The muscle metaboreflex was then engaged via
graded reductions in HLBF via partial inflation of terminal aortic occluders. Free-flow
exercise and each level of vascular occlusion were maintained until all parameters
reached steady state (typically 3-5 min). In a subset of experiments in some animals
(n=5), arterial blood samples were drawn for analysis of arterial epinephrine levels at
rest, during free-flow exercise and at peak metaboreflex activation. Epinephrine levels
were measured by high-performance liquid chromatography with electrochemical
detection (Waters, Milford, MA). Control experiments (n=11) were repeated in the same
animals after β-adrenergic blockade (2 mg/kg intra-arterial propranolol; n=7), α1adrenergic blockade (50 µg/kg intra-arterial prazosin; n=6) and α1+β blockade (n=6) on
separate days. The drugs were administered 30 minutes before each experiment and
subsequent experiments were not performed for at least 48 hours.
Data analysis
Each animal served as its own control. CO, HLBF, heart rate (HR) and mean
arterial pressure (MAP) were continuously recorded during each experimental
procedure.

Other hemodynamic parameters were calculated during off-line data

analysis (e.g., total vascular conductance (TVC) and non-ischemic vascular
conductance (NIVC)).

TVC and NIVC were calculated as CO/MAP and (CO-

HLBF)/MAP, respectively.

One minute averages of all variables were taken during

steady-state at rest, during free-flow exercise and after metaboreflex activation. Mean
values were averaged across all animals to obtain the sample mean of the study.
Statistical analysis
All hemodynamic data are reported as means ± SE. An α-level of P<0.05 was
used to determine statistical significance. Averaged responses for each animal were
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analyzed with Systat software (Systat 11.0).

A two-way ANOVA with repeated

measures was used to compare hemodynamic data for time and/or conditional effects.
In the event of a significant time-condition interaction, individual means were compared
using the Test for Simple Effects.
Results
Figure 2.1 shows two minutes of steady state levels of MAP, CO, NIVC and
HLBF during rest, mild (3.2 kph) exercise and muscle metaboreflex activation in a
control experiment. From rest to exercise, there is negligible change in MAP but a
moderate increase in CO, NIVC and HLBF.

Muscle metaboreflex activation during

exercise resulted in large increases in MAP and CO with a small increase in NIVC.
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Non-Ischemic
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Figure 2.1. Data from one control experiment showing mean arterial pressure (MAP),
cardiac output (CO), non-ischemic vascular conductance (NIVC) and hindlimb blood flow
(HLBF) during rest, exercise and metaboreflex activation.
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Figure 2.2 shows the average arterial epinephrine levels during rest, mild
exercise and metaboreflex activation in control experiments. There was no change in
epinephrine levels from rest to exercise, however with metaboreflex activation, arterial
epinephrine levels increased by ~75%.

*

Arterial Epinephrine
(pg/ml)

180

Figure 2.2. Arterial epinephrine
levels during rest, exercise (EX) and
muscle
metaboreflex
activation
(MMA) in control experiments (n=5).
* p<0.05 vs. previous setting.

150
120
90
60
30
0
REST

EX

MMA

Figure 2.3 shows mean values of MAP, CO, HR and NIVC during rest, mild
exercise and metaboreflex activation in control and after β-blockade, α1-blockade and
α1+β-blockade.
Control (n=11). MAP, CO, HR and NIVC significantly increased from rest to
exercise and furthermore from exercise to muscle metaboreflex activation.
β-adrenergic blockade (n=7). CO, HR and NIVC significantly increased from rest
to exercise, however the magnitudes of these responses were significantly lower when
compared to control exercise levels.
exercise.

There was no change in MAP from rest to

Muscle metaboreflex activation significantly increased MAP, CO and HR

while NIVC was unaffected. The magnitudes of responses during muscle metaboreflex
activation for all parameters were significantly attenuated when compared to control
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responses during metaboreflex activation.
-blockade
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Figure 2.3. Average values of MAP, CO, HR and NIVC during rest, exercise (EX) and
muscle metaboreflex activation (MMA) in control experiments (open bars; n=11), after
β-adrenergic blockade (hatched bars; n=7), α1-adrenergic blockade (crosshatched bars;
n=6) and α1+β-blockade (filled bars; n=6). * p<0.05 vs. previous setting; † p<0.05 vs.
control.
α1-adrenergic blockade (n=6). Resting MAP was significantly lower while HR
was significantly higher when compared to control. CO, HR and NIVC significantly
increased from rest to exercise while there was no change in MAP.

Muscle

metaboreflex activation caused substantial increases in all parameters. Although HR
and CO increased more than in control experiments, a larger rise in NIVC also occurred
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and therefore the resultant pressor response was significantly attenuated.
α1+β-blockade (n=6). Resting CO was decreased when compared to control.
From rest to exercise, MAP remained unchanged and CO, HR and NIVC significantly
increased, although MAP and CO were still significantly lower than in control. Muscle
metaboreflex activation led to an increase in MAP while CO, HR and NIVC remained
similar to exercise levels and significantly lower than in control.
Discussion
Our principal new finding is that activation of the muscle metaboreflex during mild
dynamic exercise evokes increases in plasma epinephrine levels and subsequent β2mediated vasodilation which opposes α-adrenergic vasoconstriction. Since β2-receptors
are richly expressed in skeletal muscle, epinephrine release may partially restrain αadrenergic vasoconstriction of active skeletal muscle during metaboreflex activation,
thereby improving blood flow to the ischemic active skeletal muscle.
Muscle metaboreflex activation during dynamic exercise causes significant
increases in MAP, HR, CO and ventricular contractility (6, 13, 16-18, 29, 43, 69-71, 95).
However, the peripheral vascular responses have varied in previous studies. While
significant vasoconstriction has been seen in the renal and forelimb vascular beds (6,
29, 40, 48, 49) when taken as a whole, the total vascular conductance of all vascular
beds except the hindlimbs (termed non-ischemic vascular conductance; NIVC) usually
remains unchanged or slightly increases (6, 13, 40, 69, 78).

Inasmuch as some

individual vascular beds do constrict, the observation of no change or slight increase in
NIVC indicates that some area(s) vasodilate. What causes this vasodilation has been
unknown. Reflex increases in sympathetic nerve activity can lead to increased preganglionic sympathetic activity to the adrenal glands which can cause substantial
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increases in epinephrine release (8, 41, 45, 46).

In addition, post-ganglionic

sympathetic nerve terminals have also been shown to release epinephrine (8, 41, 45,
46). Epinephrine is a powerful systemic vasodilator especially in skeletal muscle which
is richly endowed with β2-adrenergic receptors (25, 42, 47, 86). In the present study we
saw that metaboreflex activation caused substantial increases in arterial plasma
epinephrine levels. A small, but statistically significant peripheral vasodilation occurred
which was abolished by β-adrenergic blockade and accentuated by α1-adrenergic
blockade. These results support our hypothesis that muscle metaboreflex activation
causes increases in circulating epinephrine which opposes α-mediated vasoconstriction
via β2-mediated vasodilation.

Therefore, this mechanism can possibly explain the

observed significant increase in NIVC. Metaboreflex activation after combined α1+βblockade resulted in peripheral vasoconstriction which may be due to increased
vasopressin release. We previously demonstrated that the arterial baroreflex markedly
suppresses metaboreflex-induced vasopressin release (57). With α1+β-blockade the
rise in arterial pressure with metaboreflex activation was lower thereby likely causing
less baroreflex buffering of vasopressin release; similar to that previously observed in
our laboratory after ganglionic blockade (57).
What vascular beds are responsible for the small systemic vasodilation often
seen with metaboreflex activation during dynamic exercise are not known. Inasmuch as
about 50% of total vascular conductance in dogs even at rest is skeletal muscle (28), it
is likely that some muscle beds participate in these vasodilatory responses.
Furthermore, skeletal muscle has a greater density of β2-adrenergic receptors than
other beds such as the renal or mesenteric circulations. It is also possible that the
workload of some muscle groups is increased with metaboreflex activation. Respiratory
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muscles are potential candidates as metaboreflex activation may increase ventilation (4,
43, 66). Furthermore, with ischemia of the hindlimbs, there may also be an increase in
work done by lumbar/gluteal muscles perfused by aortic branches not isolated in our
preparation. The coronary vasculature is also a likely target bed for the increased
plasma epinephrine with muscle metaboreflex activation.

However, since the

measurement of CO in our model does not include the coronary circulation (the
coronary arteries arise from the ascending aorta below the CO blood flow transducer),
β2-mediated coronary vasodilation did not contribute to the significant increase in NIVC.
During exercise, the conductance of active skeletal muscle increases, and therefore
skeletal muscle is also a likely target for β2-mediated vasodilation. Our calculation of
NIVC does not include the ischemic hindlimb vasculature, and therefore this vascular
bed does not play a role in the observed vasodilation during metaboreflex activation in
our model. To what extent muscle metaboreflex activation (and potentially epinephrine)
influences blood flow and vascular conductance to the ischemic active muscle is
unknown.
Limitations
The plasma epinephrine levels were not measured during the experiments
employing pharmacological approaches and it is possible that epinephrine levels were
different in these settings than in the control experiments. Norepinephrine released
from sympathetic nerves could potentially also activate β-adrenergic receptors (as well
as epinephrine activates α-adrenergic receptors).

However, a previous study

demonstrated that norepinephrine infusion always caused vasoconstriction (31). It is
possible that after α-adrenergic blockade norepinephrine released from sympathetic
nerves caused some dilation via activation of β-receptors. The muscle metaboreflex is
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buffered by the arterial baroreflex (40, 72) as well as by cardiac afferents (12) (and likely
by other reflexes as well). It is possible that the interaction between the metaboreflex
and other reflexes may be affected by the pharmacological perturbations employed in
the present study.
Perspectives and significance
Skeletal muscle is richly endowed with small group III/IV afferents which respond
to changes in the mechanical and chemical environment, with many receptors being
polymodal, e.g. some primarily mechano-receptors increase activity with ischemia (34,
35). Activation of skeletal muscle afferents by metabolite accumulation during ischemic
exercise leads to increased sympathetic nerve activity eliciting a powerful pressor
response. The mechanisms mediating this pressor response may vary depending on
the experimental paradigm.

When the metaboreflex is elicited during submaximal

dynamic exercise via reductions in blood flow to the active skeletal muscle, the rise in
MAP is virtually solely driven by increases in CO in both canines and humans (24, 32,
68, 70). In human studies the metaboreflex is often activated via the technique of postexercise circulatory occlusion after either static or dynamic limb exercise. The data are
mixed as to the relative roles of increases in CO vs. peripheral vasoconstriction and as
we discussed in a previous study, this may be dependent on the intensity of contraction,
type of exercise and the muscle mass involved (78). When increases in CO are limited
(e.g., maximal exercise, heart failure, etc.), metaboreflex activation leads to peripheral
vasoconstriction (6, 16, 29, 32). Since active skeletal muscle constitutes a progressively
higher proportion of total vascular conductance with increasing exercise intensity, it
becomes an increasingly more likely target for vasoconstriction in order to raise MAP.
This vasoconstriction would further reduce blood flow and induce a larger degree of
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ischemia in the active muscle causing heightened activation of the muscle
metaboreflex, which in turn would cause a positive feedback cycle by further increasing
the sympathetic tone. In such situations, release of epinephrine from adrenal glands
and/or post-ganglionic sympathetic nerve terminals causing β2-mediated vasodilation
could act to protect perfusion of the active skeletal muscle.
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CHAPTER 3 - MUSCLE METABOREFLEX ACTIVATION DURING DYNAMIC
EXERCISE VASOCONSTRICTS THE ISCHEMIC ACTIVE SKELETAL MUSCLE
(This Chapter contains previously published material. See Appendix C.)
Abstract
Metabolite accumulation due to ischemia of active skeletal muscle stimulates
group III/IV chemosensitive afferents eliciting reflex increases in arterial blood pressure
and sympathetic activity, termed the muscle metaboreflex.

We and others have

previously demonstrated sympathetically-mediated vasoconstriction of coronary, renal
and forelimb vasculatures with muscle metaboreflex activation (MMA). Whether MMA
elicits vasoconstriction of the ischemic muscle from which it originates is unknown. We
hypothesized that the vasodilation in the active skeletal muscle with imposed ischemia
becomes progressively restrained by the increasing sympathetic vasoconstriction during
MMA.

We activated the metaboreflex during mild dynamic exercise in chronically

instrumented canines via graded reductions in hindlimb blood flow (HLBF) before and
after α1-adrenergic blockade (prazosin; 50 µg/kg), β-adrenergic blockade (propranolol; 2
mg/kg) and α1+β-blockade. Hindlimb resistance was calculated as femoral arterial
pressure/HLBF. During mild exercise, HLBF must be reduced below a threshold level
before the reflex is activated. With initial reductions in HLBF, vasodilation occurred with
the imposed ischemia. Once the muscle metaboreflex was elicited, hindlimb resistance
increased.

This increase in hindlimb resistance was abolished by α1-adrenergic

blockade and exacerbated after β-adrenergic blockade. We conclude that metaboreflex
activation during submaximal dynamic exercise causes sympathetically-mediated αadrenergic vasoconstriction in the ischemic skeletal muscle. This limits the ability of the
reflex to improve blood flow to the muscle.
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Introduction
When O2 delivery to the active muscle is insufficient to meet the O2 demands,
metabolites (e.g., hydrogen ions, adenosine, lactic acid, etc.) accumulate and activate
chemosensitive group III and IV afferents (1, 9, 35, 43, 65, 75-77). Activation of these
sensory nerves elicits reflex increases in sympathetic outflow, heart rate (HR), cardiac
output (CO), ventricular contractility and arterial blood pressure, termed the muscle
metaboreflex (17, 32, 70, 76, 78, 88, 95).
When the muscle metaboreflex is engaged in normal subjects during submaximal
dynamic exercise, the reflex raises arterial blood pressure primarily by increasing CO
(17, 32, 71, 74, 78). This increase in CO raises the total blood flow available for tissue
perfusion and thereby improves blood flow to the ischemic muscle (24, 56, 59, 68).
O'Leary and Sheriff (59) concluded that metaboreflex-mediated increases in CO and
arterial pressure restore about 50% of the blood flow deficit induced by imposed partial
reductions in muscle blood flow during dynamic exercise in canines. Similarly, Rowell
et al. (68) concluded that metaboreflex activation during dynamic leg exercise in
humans partially restores blood flow to the ischemic active muscle. Sheriff et al. (73)
concluded that the substances responsible for initiating the reflex accumulate due to
reduced oxygen delivery rather than a failure of adequate washout. As blood flow, and
thereby the oxygen delivery, to the active muscle becomes insufficient, muscle afferent
activity rises and the metaboreflex elicits increases in CO which partially restores the
muscle blood flow. Therefore, the muscle metaboreflex is often regarded as a flowsensitive, flow-raising reflex: engaged by suboptimal muscle blood flow and acting to
increase total body blood flow (i.e., cardiac output) which partially restores blood flow to
the underperfused active skeletal muscle (24, 56, 59, 68). Recently, our laboratory
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concluded that muscle metaboreflex activation induces epinephrine release causing β2mediated vasodilation within skeletal muscle (37).

This may be another potential

mechanism which improves blood flow to the ischemic muscle during exercise.
We and others have shown that metaboreflex activation elicits vasoconstriction of
coronary, renal and forelimb vasculatures (3, 6, 13, 48, 49).

Further, Joyner (33)

suggested that the muscle metaboreflex may vasoconstrict the ischemic active muscle
as venous O2 saturation significantly declined with metaboreflex activation during
rhythmic forearm exercise in humans. Whether the muscle metaboreflex vasoconstricts
the ischemic active muscle from which it originates is debatable (54).

The reflex

increases in CO and MAP partially restore blood flow and oxygen delivery to the
ischemic muscle (24, 56, 59, 68). However, this restoration could be attenuated by
vasoconstriction within the ischemic muscle.

To address this controversy, we

investigated the changes in vascular tone within ischemic muscle during metaboreflex
activation. We hypothesized that with imposed reductions in skeletal muscle blood flow
during exercise, metabolic vasodilation in the ischemic skeletal muscle would be
progressively restrained by metaboreflex-mediated increase in sympathetic activity.
This vasoconstriction would be attenuated after α-adrenergic blockade and potentiated
after β-adrenergic blockade.
Methods
Experimental subjects
Six adult mongrel canines (~19-24 kg) of either sex were selected for the study.
All animals were acclimatized to the laboratory surroundings and willing to run on a
motor-driven treadmill.

All methods and procedures employed in the study were

approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne State
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University and complied with the National Institutes of Health Guide to the Care and
Use of Laboratory Animals. All animals exercised voluntarily during experimentation; no
negative reinforcement techniques were utilized.
Surgical procedures
For each of the three surgical procedures, the animals were sedated with
acepromazine (0.4-0.5 mg/kg IM) and received preoperative analgesics [carprofen (2.0
mg/kg IV), buprenorphine (0.01 mg/kg IM) and fentanyl (75–125 µg/h (72h) transdermal
delivery)]. Anesthesia was induced with ketamine (5.0 mg/kg IV) and diazepam (0.22
mg/kg IV) and maintained with isoflurane gas (1–3%). For postoperative care, animals
were closely monitored and given acepromazine (0.5 mg/kg IV) and buprenorphine
(0.05 mg/kg IV) as needed.

To avoid acute postoperative infections, cefazolin

(antibiotic, 30 mg/kg IV) was administered pre- and post-operatively.

Cephalexin

(antibiotic, 30 mg/kg PO BID) was administered prophylactically for the entire term of
the experimental protocol. The animals recovered for two weeks after each surgery.
In the first surgical procedure, the thoracic cavity was opened via a left
thoracotomy (3rd/4th intercostal space) approach and the pericardium was cut to
expose the heart. A perivascular flow probe (20PAU, Transonic Systems) was placed
around the ascending aorta to measure CO. Due to the anatomical limitation for the
aortic flow probe placement, coronary circulation is not included in the CO
measurements. In dogs at rest myocardial blood flow is approximately 6% of the total
CO and this fraction remains relatively unchanged across workloads (27, 50).

A

telemetry blood pressure transmitter (TA11 PA-D70, DSI) was tethered subcutaneously
at the height of the left ventricular apex and two intercostal spaces caudal to the
thoracotomy incision. The tip of the pressure transducer catheter was inserted and
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secured inside the left ventricle to measure left ventricular pressure.

Three pacing

electrodes were secured to the right ventricular free wall for studies unrelated to the
present investigation. All wires were tunneled subcutaneously and exteriorized between
the scapulae. The pericardium was reapproximated and the chest was closed in layers.
In the second surgical procedure, an incision was made on the left flank cranial
to the iliac crest to expose the abdominal aorta and left renal artery. Perivascular flow
probes (Transonic Systems) were positioned around the terminal aorta (10PAU) and the
left renal artery (4PSB) to measure hindlimb blood flow (HLBF) and renal blood flow,
respectively. All side branches of the terminal aorta between the iliac arteries and the
aortic flow probe were ligated and severed. Two hydraulic occluders (8-10 mm, DocXS
Biomedical Products) were placed around the terminal aorta just distal to the flow probe.
A 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was inserted into a side branch
of the aorta cranial to the flow probe to measure systemic arterial pressure. A second
19-gauge polyvinyl catheter was inserted into a side branch of the aorta caudal to the
occluders to measure arterial pressure below the occluders. When the catheterization
of a caudal aortic branch was not possible in this surgery, a catheter was placed into a
side branch of the femoral artery in a third procedure. All instrumentation was tunneled
subcutaneously and exteriorized between the scapulae and the abdomen was closed in
layers. For experiments unrelated to this study, a catheter was inserted into the right
jugular vein (n=2) and a hydraulic occluder was placed around each common carotid
artery in a separate procedure.
Data acquisition
Each animal was brought into the laboratory and allowed to roam freely and
acclimate for ~10-20 minutes, following which it was directed onto the treadmill. The
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flow probe cables were connected to flow meters (TS420, Transonic Systems). The two
arterial catheters were aspirated, flushed and connected to pressure transducers
(Transpac IV, ICU Medical). All hemodynamic variables were monitored as real-time
waveforms by a data acquisition system (LabScribe2, iWorx) and recorded for
subsequent off-line analysis.
Experimental procedures
All experiments were performed after the animals had fully recovered from
surgery (i.e., were active and of good appetite). Each experiment began with the animal
standing still on the treadmill until all resting hemodynamic data were stable (typically 510 min). The treadmill was turned on and the speed was gradually increased to 3.2 kph
at 0% grade. To activate the muscle metaboreflex, HLBF was reduced to ~40% of freeflow exercise levels via graded reductions (by partial inflation of terminal aortic
occluders). Free-flow exercise and each level of vascular occlusion were maintained
until all hemodynamic parameters reached steady state (typically 3-5 min). Control
experiments were repeated in the same animals after α1-adrenergic blockade (prazosin
50 µg/kg intra-arterial), β-adrenergic blockade (propranolol 2 mg/kg intra-arterial) and
α1+β blockade on separate days. The drugs were administered 20-30 minutes before
the experiment and subsequent experiments were not performed for at least 48 h. The
large vasoconstrictor effect of phenylephrine was completely abolished with 50 µg/kg
dose of prazosin.

Preliminary studies showed that 2 mg/kg dose of propranolol

completely abolished the vasodilatory response caused by isoproterenol (0.5 µg/kg).
Animals performed the same exercise workload after each blockade as during control
experiments.
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Data analysis
Mean arterial pressure (MAP), femoral arterial pressure (FAP), HR, CO and
HLBF were continuously recorded during each experimental procedure. Hindlimb
vascular resistance was calculated as FAP/HLBF. Vascular conductance to all vascular
beds with the exception of the hindlimb (termed non-ischemic vascular conductance,
NIVC) was calculated as NIVC = (CO-HLBF)/MAP.

One minute averages of all

variables were taken during steady-state at rest, free-flow exercise and each graded
reduction in HLBF. The data were analyzed as initially described by Wyss et al. (95).
Previous studies have shown that during mild exercise in canines HLBF must be
reduced below a clear threshold before the muscle metaboreflex is activated (6, 73, 95).
Initial reductions in HLBF did not evoke metaboreflex responses while reductions in
HLBF below the threshold resulted in a significant pressor response. Therefore, the
data were approximated to two linear regression lines: an initial slope line that includes
free-flow exercise and each reduction in blood flow that did not elicit reflex response,
and a pressor slope line that includes reductions in HLBF that resulted in a large
pressor response (Figure 3.2).

The threshold for metaboreflex activation was

approximated as the intersection of the initial and pressor slope lines. Mean values
were averaged across all animals to obtain the sample mean of the study. Each animal
served as its own control.
Statistical analysis
All hemodynamic data are reported as means ± SE. An α-level of P<0.05 was
used to determine statistical significance. Averaged responses for each animal were
analyzed with Systat software (Systat 11.0).

A two-way ANOVA with repeated

measures was used to compare hemodynamic data for time and/or condition effects. In
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the event of a significant time-condition interaction, individual means were compared
using the Test for Simple Effects.
Results
Figure 3.1 shows 5 second averages of MAP, CO, HLBF and hindlimb resistance
in a control experiment during rest, mild (3.2 kph) exercise and graded reductions in
HLBF. From rest to exercise, hindlimb resistance decreased and HLBF increased along
with the rise in CO. Initial graded reductions in HLBF did not evoke changes in MAP or
CO, but caused further decreases in hindlimb resistance. When reductions in HLBF
elicited the metaboreflex, marked increases in MAP and CO occurred and despite the
continued progressive hindlimb ischemia, hindlimb vascular resistance rose indicating
that vasoconstriction occurred.
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Figure 3.1. Data from one control experiment showing mean arterial pressure (MAP),
cardiac output (CO), hindlimb blood flow (HLBF), and hindlimb resistance during rest,
exercise (Ex) and graded reductions in HLBF eliciting the muscle metaboreflex.
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Figure 3.2. The initial and pressor slopes
of mean arterial pressure (top panel) and
hindlimb resistance (bottom panel)
obtained by dual linear regression model
from a control experiment.

Figure 3.2 shows the relationships between MAP vs. HLBF (top) and hindlimb
resistance vs. HLBF (bottom) from a control experiment. Figure 3.3 shows average
hindlimb resistance responses as a function of HLBF in control, after α1-adrenergic
blockade, β-adrenergic blockade and α1+β-blockade.

Figure 3.3. Hindlimb resistance responses during free-flow exercise, metaboreflex
threshold and maximal metaboreflex activation (n=6) for control (open circles) vs. α1blockade (filled triangles) (left), control vs. β-blockade (filled squares) (center) and
control vs. α1+β-blockade (filled diamonds) (right). * p<0.05 vs. previous setting in same
experiment; † p<0.05 vs. control setting.
Control. Initial reductions in HLBF caused a significant decrease in hindlimb
vascular resistance. Once HLBF was reduced below threshold, there was a significant
increase in hindlimb resistance.
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α1-adrenergic blockade. Initial HLBF reductions above the threshold caused a
significant decrease in hindlimb resistance as in control. However, when HLBF was
reduced below threshold, the increase in resistance observed in control was abolished
revealing a continued decrease in resistance. The magnitude of hindlimb resistance
during maximal metaboreflex activation was significantly lower than control.
β-adrenergic blockade. During free-flow exercise, hindlimb resistance was
significantly higher than control. With initial reductions in HLBF, hindlimb resistance
significantly decreased to a level not different from control. Following metaboreflex
activation, there was a significant increase in hindlimb resistance. The magnitude of
resistance at maximal metaboreflex activation was significantly larger than in control.
α1+β-blockade. With initial reductions in HLBF, hindlimb resistance decreased to
a level not different from control. Following metaboreflex activation, there was a small
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Figure 3.4. Initial and pressor slope responses of hindlimb vascular resistance during
muscle metaboreflex activation (n=6) in control (open bars), after α1-adrenergic
blockade (hatched bars), β-adrenergic blockade (cross-hatched bars), and α1+βblockade (filled bars). * p<0.05 vs. initial slope; † p<0.05 vs. control setting.
Figure 3.4 shows average slopes of the relationship between hindlimb vascular
resistance vs. hindlimb blood flow during the initial and pressor responses in control and
following α1-blockade, β-blockade and α1+β-blockade. In control, the initial slope was
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significantly different from the pressor slope. After α1-adrenergic blockade, the initial
and pressor slopes were not significantly different from each other. The initial slope
after α1-blockade was similar to that in control while the pressor slope was reversed and
significantly different from control. After β-blockade, the initial and pressor slopes were
significantly different from each other and the pressor slope was markedly larger (more
negative) than in control.

After α1+β-blockade, the two slopes were significantly

different from each other but not from control.
Table 3.1. Mean hemodynamic values during rest, mild exercise (EX) and muscle
metaboreflex activation (MMA) in control and after α1-blockade, β-blockade and α1+βblockade in normal animals.
MAP
(mmHg)

Rest
Ex
MMA
CO
Rest
(l/min)
Ex
MMA
HR
Rest
(bpm)
Ex
MMA
NIVC
Rest
(ml/min/mmHg) Ex
MMA
HLBF
Rest
(l/min)
Ex
MMA

Control
88.4 ± 1.9
92.1 ± 1.2 *
143.6 ± 1.6 *
2.75 ± 0.15
4.32 ± 0.23 *
6.50 ± 0.27 *
69.9 ± 4.2
101.0 ± 2.8 *
141.0 ± 3.6 *
24.3 ± 1.3
34.2 ± 1.7 *
41.4 ± 1.7 *
0.60 ± 0.07
1.18 ± 0.13 *
0.55 ± 0.04

α1-blockade
81.4 ± 1.4 †
83.5 ± 1.6 *†
119.5 ± 3.4 *†
2.87 ± 0.18
4.48 ± 0.21 *
6.66 ± 0.21 *
83.2 ± 5.5 †
112.9 ± 4.8 *†
159.4 ± 8.6 *†
28.1 ± 2.2 †
39.6 ± 2.6 *†
50.8 ± 1.7 *†
0.60 ± 0.04
1.20 ± 0.09 *
0.64 ± 0.05 †

β-blockade
84.4 ± 2.2
90.3 ± 3.5 *
114.4 ± 5.4 *†
2.59 ± 0.10
3.71 ± 0.25 *†
4.11 ± 0.23 *†
70.4 ± 3.1
95.3 ± 1.0 *†
104.3 ± 4.3 †
24.6 ± 1.2
29.7 ± 1.3 *†
31.5 ± 1.3 †
0.52 ± 0.05
1.02 ± 0.12 *†
0.52 ± 0.04

α1+β-blockade
76.9 ± 2.0 †
81.5 ± 1.9 †
113.7 ± 4.8 *†
2.70 ± 0.16
4.03 ± 0.24 *
4.71 ± 0.32 *†
80.3 ± 4.4
106.6 ± 4.7 *
119.6 ± 6.7 *†
27.9 ± 1.8 †
36.3 ± 1.7 *
36.4 ± 1.9 †
0.55 ± 0.04
1.07 ± 0.13 *
0.56 ± 0.04

Mean hemodynamic values during rest, free-flow exercise and maximal metaboreflex activation during
control experiments and following α1-blockade, β-blockade and α1+β-blockade in six animals, represented
as means ± SE. MAP, mean arterial pressure; CO, cardiac output; HR, heart rate; NIVC, non-ischemic
vascular conductance; HLBF, hindlimb blood flow; *P<0.05 vs. previous setting in same experiment;
†P<0.05 vs. control.

Table 3.1 shows mean hemodynamic data during rest, mild exercise and muscle
metaboreflex activation in control experiments and following α1-blockade, β-blockade
and α1+β-blockade. From rest to exercise in control, there were significant increases in
MAP, CO, HR, NIVC and HLBF.

With muscle metaboreflex activation, there were
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further significant increases in MAP, CO, HR and NIVC.

Following α1-adrenergic

blockade, resting MAP was significantly lower while HR and NIVC were significantly
higher than in control.

With mild exercise there was a significant increase in all

variables and MAP, HR and NIVC were significantly higher than control exercise levels.
Muscle metaboreflex activation following α1-blockade resulted in substantial increases
in MAP, CO, HR and NIVC with a significantly attenuated pressor response compared
to control. Following β-adrenergic blockade, all the parameters increased with exercise
but the levels of CO, HR, NIVC and HLBF were significantly lower than those observed
during control experiments.

Muscle metaboreflex activation significantly increased

MAP, CO, and HR while NIVC was unchanged and all parameters were significantly
attenuated compared with metaboreflex responses in control. Following α1+β-blockade,
resting MAP and NIVC was lower than in control. From rest to exercise, CO, HR, NIVC
and HLBF significantly increased while MAP remained unchanged and was significantly
lower than in control. Muscle metaboreflex activation led to an increase in MAP, CO
and HR but all responses were significantly lower than in control.
Discussion
The major new finding of this study is that muscle metaboreflex-induced
increases in sympathetic activity cause vasoconstriction of the ischemic active skeletal
muscle from which the metaboreflex originates.

Inasmuch as metaboreflex-induced

increases in CO and arterial blood pressure partially restore blood flow to the ischemic
muscle, sympathetically-mediated vasoconstriction would limit the ability of the
metaboreflex to improve blood flow to the ischemic muscle.
The muscle metaboreflex is activated when oxygen supply to the muscle is
unable to meet the metabolic demands of the active muscle (73, 95). During mild
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exercise in canines, initial reductions in HLBF did not cause any marked increases in
MAP, CO or HR, indicating adequate oxygen supply to the working muscle. With further
reductions in HLBF oxygen supply becomes insufficient to meet the oxygen demand of
the active muscle leading to accumulation of metabolites (H+, lactic acid, diprotonated
phosphate, etc.) (9, 65, 75-77). As a result, the muscle metaboreflex is activated and
marked elevations in MAP, CO, HR and ventricular contractility are observed (13, 16,
17, 70, 78, 95). Thus, during mild dynamic exercise in canines there is a clear threshold
before the muscle metaboreflex is activated (Figure 3.2).
In control, initial reductions in HLBF resulted in metabolic vasodilation as
indicated by a decrease in hindlimb vascular resistance (Figure 3.3). When reductions
in HLBF below the threshold elicited the metaboreflex, metabolic vasodilation was
opposed by vasoconstriction as indicated by an increase in vascular resistance within
the ischemic muscle.

Following α1-blockade, the vasoconstriction observed during

metaboreflex activation in control was abolished, revealing a continued vasodilation in
the ischemic vasculature with further reductions in hindlimb blood flow. These findings
indicate that muscle metaboreflex activation induces α1-mediated sympathetic
vasoconstriction within the ischemic skeletal muscle. After β-blockade, metaboreflex
activation caused a significantly larger vasoconstriction in the hindlimb vasculature than
in control.

These findings are in agreement with our previous work demonstrating

metaboreflex-induced β2-mediated vasodilation in ischemic skeletal muscle (37).
Following α1+β-blockade, metaboreflex activation resulted in a vasoconstriction not
significantly different from control.

This could be due to the contribution of other

hemodynamic factors such as vasopressin, endothelin, neuropeptide Y etc., and/or a
potential α2-mediated vasoconstriction (7, 10, 19, 30, 57). Therefore, vasomotor tone of
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the ischemic muscle with muscle metaboreflex activation during submaximal exercise is
a combined result of a complex interplay between metabolic vasodilation and
neurogenic and circulating vasoconstrictor factors as well as possible local factors
released from the endothelium. In the control experiments, the prevailing neurogenic
vasoconstriction results in frank vasoconstriction within the ischemic vasculature.
We and others have shown that metaboreflex activation elicits vasoconstriction of
coronary, renal and forelimb vasculatures (3, 6, 13, 48, 49).

Whether the muscle

metaboreflex vasoconstricts the ischemic muscle itself has been controversial (33, 54,
59).

Muscle metaboreflex activation during dynamic exercise in canines markedly

increases MAP and CO which restores about half of the blood flow deficit to the
ischemic skeletal muscle (59). In humans, Rowell et al. (68) showed that metaboreflex
activation in normal subjects partially restores blood flow to ischemic muscle. Eiken and
Bjurstedt (24) reached similar conclusions whereas Joyner (33) suggested that a reflexinduced sympathetic vasoconstriction in the ischemic muscle limits the restoration of
blood flow. Several factors could contribute to these conflicting findings: 1) the studies
performed in humans did not directly measure blood flow, blood pressure or
sympathetic nerve activity within the active skeletal muscle, 2) the exercise intensity,
muscle mass and muscle type involved in the exercise were different and 3) species
differences may exist in the extent of metaboreflex activation (2, 6, 68, 95). This is the
first study to directly measure arterial pressure and blood flow within the ischemic active
muscle.

We show that metaboreflex activation induces α1-mediated sympathetic

vasoconstriction within the ischemic active muscle. If no sympathetic vasoconstriction
occurred with metaboreflex activation, the amount of blood flow restoration to the
ischemic vasculature would have been larger than 50%.

Therefore, muscle
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metaboreflex-induced neurogenic vasoconstriction limits the ability of the reflex to
restore blood flow to the muscle.
Vasoconstriction within the ischemic muscle would result in a decrease in muscle
blood flow which would lead to exaggerated metaboreflex activation. Therefore, this
becomes a positive feedback loop wherein vasoconstriction decreases the blood flow to
the already ischemic muscle, further activating muscle afferents and causing a larger
vasoconstriction.

However, the positive feedback could either become run-away

positive feedback, where each cycle would lead to exaggerated metaboreflex activation
and a larger vasoconstriction, or become limiting positive feedback, where the stimulus
and the response progressively become smaller and reach a plateau. Whether this
positive feedback loop becomes a run-away cycle of continuing amplified responses or
serves as an amplifier of the initial responses which reaches a plateau depends on the
magnitude of the change in sympathetic activity engendered by the reflex and the
efficacy of this change in sympathetic activity on blood flow to the ischemic muscle.
That is, if the rise in sympathetic activity elicited by a one unit decrease in muscle blood
flow evokes vasoconstriction in the muscle which causes a less than one unit fall in
flow, then the positive feedback will cycle with ever decreasing amplitude and eventually
plateau at a heightened response. If however, the fall in blood flow caused by the rise
in sympathetic activity is greater than the change in flow which caused the rise in
sympathetic activity itself, then this becomes a “run-away” positive feedback with ever
increasing responses eventually leading to complete vasoconstriction.

Using the

average results in our study, the pressor slope for the relationship between the imposed
decrease in HLBF and the observed increase in hindlimb vascular resistance was -36
units which indicates that for every l/min decrease in flow, there would be a 36
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mmHg/l/min increase in resistance. This 36 mmHg/l/min increase in resistance caused
by metaboreflex activation would itself cause a decrease in flow. At the threshold level
of HLBF, an increase in hindlimb resistance by 36 mmHg/l/min would cause a 0.54 l/min
further decrease in flow if pressure remained constant. This decrease in flow would
additionally increase resistance by 19.7 mmHg/l/min which in turn would decrease flow
by 0.15 l/min and so forth.

With each cycle, the increase in the stimulus and the

resultant reflex response becomes progressively smaller and the positive feedback will
eventually reach a steady state. Whereas a variety of factors can affect the hindlimb
resistance response, our results indicate that this is a limiting positive feedback which is
a stable system resulting in amplified gain rather than run-away instability.
In canines, nearly half of the CO at rest perfuses skeletal muscle (28) and during
exercise all of the rise in CO is directed to the active skeletal muscle (50). When further
increases in CO become limited (e.g., during severe exercise, heart failure, following βblockade, etc.), peripheral vasoconstriction is the only mechanism available to increase
arterial pressure. Since the active skeletal muscle constitutes a large proportion of total
vascular conductance during severe exercise, the ischemic active muscle is the likely
target for progressively larger vasoconstriction. Several studies indicate that metabolic
by-products in skeletal muscle reduce neurogenic vasoconstriction, termed functional
sympatholysis (63, 85). Although to some extent conclusions may also be dependent
on methods of data analysis (52).

In patho-physiological states functional

sympatholysis may be reduced (85, 90) which may thereby heighten vasoconstrictor
responses in the ischemic muscle in these settings. This would further limit O2 delivery
to the ischemic muscle leading to an exaggerated activation of the muscle
metaboreflex, stimulating a dangerous positive feedback loop.

To what extent this
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metaboreflex positive feedback approaches run-away levels in pathophysiological
states is unknown. Fundamentally, this feedback could impair the ability to exercise
and contribute to exercise intolerance.
Limitations
The arterial baroreflex buffers about one-half of the muscle metaboreflex-induced
pressor response and this occurs primarily by inhibition of peripheral vasoconstriction
(40). In our study, MAP during muscle metaboreflex activation after α1- and β-blockade
was significantly smaller than in control. This lower arterial pressure could potentially
result in a reduced buffering by the baroreflex and cause larger metaboreflex-induced
peripheral vasoconstriction.

A larger vasoconstrictor drive could limit the hindlimb

vasodilation we observed with metaboreflex activation after α1-blockade and could
exaggerate the vasoconstriction we observed after β-blockade.

Our observation of

continued hindlimb vasodilation after α1-blockade despite possible larger sympathetic
activation would argue in favor of our conclusion that sympathetic vasoconstriction
occurs in the ischemic hindlimb during metaboreflex activation.

The larger

vasoconstriction seen after β-blockade may have been exaggerated due to the lower
arterial pressure and less baroreflex buffering of the metaboreflex responses.
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CHAPTER 4 - MUSCLE METABOREFLEX-INDUCED VASOCONSTRICTION OF THE
ISCHEMIC ACTIVE MUSCLE IS EXAGGERATED IN HEART FAILURE
Abstract
When oxygen delivery to active muscle is insufficient to meet metabolic
demands, metabolites accumulate and stimulate skeletal muscle afferents inducing a
reflex rise in blood pressure, termed the muscle metaboreflex. Muscle metaboreflex
activation (MMA) during submaximal dynamic exercise increases arterial pressure
virtually solely via an increase in cardiac output (CO), as no net peripheral
vasoconstriction occurs.

In heart failure (HF), increases in CO are limited and

metaboreflex-induced pressor responses occur via peripheral vasoconstriction.

We

recently demonstrated that MMA induces sympathetic vasoconstriction in the ischemic
active muscle, limiting the ability of the metaboreflex to restore blood flow.

In the

present study we tested the hypothesis that vasoconstriction in the ischemic muscle is
exaggerated in HF.

Changes in hindlimb vascular resistance (femoral arterial

pressure/hindlimb blood flow (HLBF)) were observed during MMA induced via graded
reductions in HLBF during mild exercise with and without α1-adrenergic blockade
(prazosin; 50 µg/kg) before and after the induction of HF. During mild exercise, HLBF
must be reduced below a clear threshold before MMA occurs. In normal animals, initial
HLBF reductions caused metabolic vasodilation while reductions below the MMA
threshold elicited reflex vasoconstriction in the ischemic muscle which was abolished
following α1-adrenergic blockade.

MMA-induced vasoconstriction of the ischemic

muscle was exaggerated after induction of HF.

This heightened vasoconstriction

impairs the ability of the metaboreflex to restore blood flow to ischemic muscle in HF
and may contribute to exercise intolerance observed in these patients. We conclude
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that sympathetically-mediated vasoconstriction of the ischemic skeletal muscle during
muscle metaboreflex activation is exaggerated in HF.
Introduction
Ischemia in the exercising skeletal muscle causes accumulation of metabolites
(e.g., protons, diprotonated phosphate, lactic acid, etc.) which activate the
chemosensitive muscle afferents eliciting a reflex pressor response, termed the muscle
metaboreflex (1, 9, 35, 77).

Muscle metaboreflex activation in healthy individuals

increases heart rate (HR), cardiac output (CO), mean arterial pressure (MAP),
ventricular contractility and right atrial pressure (17, 70, 71, 78, 88) along with some
regional vasoconstriction (6, 13, 48, 49).
During submaximal dynamic exercise in normal subjects, muscle metaboreflexinduced pressor response, primarily driven by an increase in CO (6, 17, 32), partially
restores blood flow to ischemic active muscle (24, 59, 70).

Muscle metaboreflex-

induced epinephrine release resulting in β2-mediated vasodilation within the skeletal
muscle (37) is another viable mechanism for blood flow restoration to ischemic active
muscle. We recently showed however, that the very muscle from which the muscle
metaboreflex originates is itself a target vasculature for sympathetically-mediated
vasoconstriction during muscle metaboreflex activation (36). This functionally limits the
ability of metaboreflex to restore blood flow to the ischemic muscle.
The strength and mechanisms of metaboreflex activation are altered in heart
failure (HF) (14, 29, 51, 81). HF is characterized by low resting CO and heightened
sympathetic nerve activity (SNA). Inasmuch as metaboreflex-induced increases in CO
and ventricular contractility are substantially attenuated in HF, the pressor response
occurs due to enhanced vasoconstriction of the peripheral vasculature (14, 16, 29, 58).

40
Whether the ischemic muscle itself undergoes exaggerated reflex vasoconstriction is
unknown. Therefore, in this study, we investigated whether the vasoconstriction in the
ischemic active skeletal muscle is exaggerated in HF.
Methods
Experimental subjects
Six adult mongrel canines (~19-24 kg) of either sex were selected for the study
for their willingness to walk on a motor-driven treadmill. All methods and procedures
employed in the study were approved by the Institutional Animal Care and Use
Committee (IACUC) of Wayne State University and complied with the National Institutes
of Health Guide to the Care and Use of Laboratory Animals.

All animals were

acclimatized to the laboratory surroundings and exercised voluntarily during
experimentation; no negative reinforcement techniques were utilized.
Surgical procedures
For each surgical procedure, anesthesia was induced with ketamine (5 mg/kg IV)
and diazepam (0.2-0.3 mg/kg IV) and maintained with isoflurane gas (1–3%).

The

animals received preoperative analgesics [carprofen (4.4 mg/kg IV), buprenorphine
(0.01-0.03 mg/kg IM) and fentanyl (75–125 µg/h (72h) transdermal delivery)].
Acepromazine (0.2-0.3 mg/kg IV) and buprenorphine (0.01-0.03 mg/kg IM) was given
during postoperative care. To avoid acute postoperative infections, cefazolin (antibiotic,
30 mg/kg IV) was administered pre- and post-operatively. Cephalexin (antibiotic, 30
mg/kg PO BID) was administered prophylactically for the entire term of the experimental
protocol.
In the first surgical procedure, the heart was exposed via a left thoracotomy
(3rd/4th intercostal space) approach.

A 20 mm blood flow transducer (Transonic
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Systems) was placed around the ascending aorta to measure CO.

A telemetry

pressure transmitter (TA11 PA-D70, DSI) was tethered subcutaneously and its tip was
secured inside the left ventricle to measure left ventricular pressure. Three stainless
steel pacing electrodes (0-Flexon) were secured to the right ventricle. All wires were
tunneled subcutaneously and exteriorized between the scapulae. The chest was closed
in layers after reapproximating the pericardium.
In the second surgical procedure, the abdominal aorta was exposed via a left
flank incision cranial to the iliac crest.

A 10 mm blood flow transducer (Transonic

Systems) was placed around the terminal aorta to measure hindlimb blood flow (HLBF)
and two hydraulic occluders (8-10 mm, DocXS Biomedical Products) were placed just
distal to it. All side branches of the terminal aorta between the iliac arteries and the
aortic flow probe were ligated. A 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton)
was inserted into a side branch of the aorta to measure systemic arterial pressure. A
second 19-gauge polyvinyl catheter was inserted into a side branch of the aorta caudal
to the occluders to measure arterial pressure below the occluders.

When the

catheterization of a caudal aortic branch was not possible in this surgery, a catheter was
placed into a side branch of the femoral artery in a separate procedure.

All

instrumentation was tunneled subcutaneously and exteriorized between the scapulae.
The abdomen was closed in layers. For experiments unrelated to this study, a 4 mm
flow probe was placed around the left renal artery during retroperitoneal surgery and
hydraulic occluders were placed around common carotid arteries in a separate
procedure.
Data acquisition
Before each experiment, the animal was brought into the laboratory and allowed
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to roam freely and acclimate for ~10-20 minutes. Then, the animal was led to the
treadmill, arterial catheters were connected to pressure transducers, left ventricular
telemetry implant was turned on and flow probes were connected to flow meters
(Transonic Systems).

All hemodynamic variables were monitored as real-time

waveforms by a data acquisition system (LabScribe2, iWorx) and recorded for
subsequent off-line analysis.
Experimental procedures
Animals recovered for at least two weeks after each surgery. Experiments were
performed after the animals had fully recovered from surgery (i.e., were active and of
good appetite). During each experiment, resting steady-state hemodynamic parameters
were recorded with the animal standing on the treadmill followed by mild exercise (3.2
kph at 0% grade). The muscle metaboreflex was activated via graded reductions in
HLBF (by partial inflation of terminal aortic occluders) during mild exercise. Free-flow
exercise and each reduction in HLBF were maintained until all hemodynamic
parameters reached steady state (~3-5 min). Control experiments were repeated in the
animals after α1-adrenergic blockade (prazosin 50 µg/kg intra-arterial). The drug was
administered 20-30 minutes before the experiment and no subsequent experiments
were performed for next 48 hours.

In each experiment, the dose of prazosin was

sufficient to abolish the large vasoconstrictor effect of phenylephrine (4 µg/kg). After the
completion of experiments in normal animals, heart failure was induced via rapid
ventricular pacing (220-240 beats/min) for a group average of 32 ± 4 days.

The

development of HF was established by resting tachycardia and decreases in resting
mean arterial pressure (MAP), CO, maximal rate of the rise in left-ventricular pressure
(dP/dtmax) and maximal rate of fall in left-ventricular pressure (dP/dtmin) (Table 4.1).
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Data analysis
MAP, femoral arterial pressure (FAP), HR, CO, left ventricular pressure and
HLBF were continuously recorded during each experimental procedure.

Hindlimb

vascular resistance was calculated as FAP/HLBF. Vascular conductance to all vascular
beds except the hindlimb (termed non-ischemic vascular conductance, NIVC) was
calculated as NIVC = (CO-HLBF)/MAP. One minute averages of all variables were
taken during steady-state at rest, free-flow exercise and each graded reduction in
HLBF. Inasmuch as the HLBF during mild exercise in canines must be reduced below a
clear threshold before the muscle metaboreflex is activated (6, 73, 95), initial reductions
in HLBF did not evoke any metaboreflex responses while reductions in HLBF below the
threshold resulted in a significant pressor response.

Therefore, the data were

approximated to two linear regression lines: an initial slope line that includes free-flow
exercise and each reduction in blood flow that did not elicit reflex response, and a
pressor slope line that includes reductions in HLBF that resulted in large pressor
response (Figure 4.2). The threshold for metaboreflex activation was approximated as
the intersection of the initial and pressor slope lines.

Mean values were averaged

across all animals to obtain the sample mean of the study. Each animal served as its
own control.
Statistical analysis
All hemodynamic data are reported as means ± SE. An α-level of P<0.05 was
used to determine statistical significance. Averaged responses for each animal were
analyzed with Systat software (Systat 11.0).

A two-way ANOVA with repeated

measures was used to compare hemodynamic data for time and/or condition effects. In
the event of a significant time-condition interaction, individual means were compared
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using the Test for Simple Effects.
Results
Figure 4.1 MAP, CO and HLBF in a control experiment during rest, mild exercise
and muscle metaboreflex activation induced by graded reductions in HLBF (data are
averaged over every 5 seconds for clarity).

From rest to exercise, MAP remained

unchanged while CO and HLBF increased. With initial graded reductions in HLBF,
there was a small increase in both MAP and CO. When further reductions in HLBF
elicited the muscle metaboreflex, marked increases in MAP and CO occurred. Figure
4.2 shows the relationships between MAP vs. HLBF and hindlimb resistance vs. HLBF
during the control experiment. Initial reductions in HLBF caused a small increase in
MAP and a decrease in hindlimb resistance. Once metaboreflex threshold is reached,
further reductions in HLBF caused large reflex increase in MAP and hindlimb
resistance.
Figure 4.1. Data from
one control experiment
showing mean arterial
pressure, cardiac output
and hindlimb blood flow
during rest, mild free-flow
exercise (Ex) and muscle
metaboreflex activation
(MMA)
induced
via
graded reductions in
hindlimb blood flow.
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Figure 4.2. Initial and pressor slopes
of mean arterial pressure (top) and
hindlimb resistance (bottom) obtained
by using dual linear regression model
in a control experiment.

Figure 4.3 shows average hindlimb resistance responses as a function of HLBF
in control and α1-adrenergic blockade experiments before and after induction of HF.
During control experiments in healthy animals, initial reductions in HLBF caused a
significant decrease in hindlimb vascular resistance, indicating vasodilation in the
hindlimb skeletal muscle.

Once HLBF was reduced below threshold, there was a

significant increase in hindlimb resistance indicating vasoconstriction of the ischemic
skeletal muscle. Following α1-adrenergic blockade, initial HLBF reductions caused a
similar decrease in hindlimb resistance as in control.

However, once HLBF was

reduced below threshold, the vasoconstriction observed in control was completely
abolished, hindlimb resistance continued to fall with further reductions in HLBF and at
maximal metaboreflex activation hindlimb resistance was significantly lower than
control. After induction of HF in the same animals, hindlimb resistance during free-flow
exercise was significantly higher than in healthy subjects and HLBF was significantly
lower (Table 4.1). Hindlimb resistance decreased with initial reductions in HLBF and
markedly increased in response to metaboreflex activation.
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Figure 4.3. Average hindlimb resistance responses during free-flow exercise,
metaboreflex threshold and maximal metaboreflex activation during control (open
circles) and α1-blockade (filled circles) experiments in normal (left panel) and heart
failure (right panel). *p<0.05 vs. previous setting in same experiment; † p<0.05 vs.
control; ‡ p<0.05 vs. normal.
Hindlimb resistance at maximal metaboreflex activation was significantly higher
than in healthy subjects.

Following α1-blockade in HF animals, hindlimb resistance

during free-flow exercise was significantly lower and HLBF was markedly higher than
during control experiment in HF animals. Initial reductions in HLBF led to a decrease in
hindlimb resistance, indicating vasodilation. Following muscle metaboreflex activation,
the large vasoconstriction observed in control experiments in HF was completely
abolished.
Figure 4.4 shows average slopes of the relationship between hindlimb vascular
resistance and HLBF during control and α1-blockade experiments before and after
induction of HF. During control experiments in healthy subjects, the initial slope was
significantly different from the pressor slope. After α1-adrenergic blockade, the initial
and pressor slopes were not significantly different from each other. The initial slope
after α1-blockade was similar to that in control while the pressor slope was reversed and
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significantly different from control. After induction of HF, the initial and pressor slopes
were significantly different from each other and markedly larger than in normal subjects.
After α1-adrenergic blockade in HF animals, the two slopes were significantly different
from each other and from the control experiments in HF.

NORMAL

Slope of Hindlimb Resistance
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†
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0
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‡

Pressor

†

†

50

*

0

*

-50
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-100

-150

-150

*
‡

Figure 4.4. Average initial and pressor slope values of hindlimb resistance during
control (open bars) and α1-blockade (filled bars) experiments in normal (left panel) and
heart failure (right panel) animals. *p<0.05 vs. initial slope; † p<0.05 vs. control; ‡
p<0.05 vs. normal.
Table 1 shows mean hemodynamic data during rest, mild exercise and muscle
metaboreflex activation in control and α1-blockade experiments in normal and HF
animals. From rest to exercise in control, there were significant increases in MAP, CO,
HR, NIVC, HLBF and ventricular contractility.

With muscle metaboreflex activation,

there were further significant increases in MAP, CO, HR, NIVC, and indices of
ventricular inotropic and lusitropic state. Following α1-adrenergic blockade in normal
animals, resting MAP was significantly lower while NIVC and contractility were
significantly higher than in control. With mild dynamic exercise there was a significant
increase in all variables and MAP, CO, NIVC, and dP/dtmax were markedly higher than
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control exercise levels. Muscle metaboreflex activation following α1-blockade resulted
in substantial increases in MAP, CO, HR, NIVC dP/dtmax and dP/dtmin.

The reflex-

induced pressor response following α1-blockade was significantly attenuated compared
to control while CO, NIVC and ventricular contractility during maximal metaboreflex
activation was substantially higher that during control.
Table 4.1. Mean hemodynamic values during rest, mild exercise (EX) and muscle
metaboreflex activation (MMA) before and after α1-blockade in normal and heart failure
animals.
NORMAL
HEART FAILURE
MAP
(mmHg)

Rest
Ex
MMA
CO
Rest
(l/min)
Ex
MMA
HR
Rest
(bpm)
Ex
MMA
NIVC
Rest
(ml/min/mmHg) Ex
MMA
HLBF
Rest
(l/min)
Ex
MMA

Control
89.1±1.8
91.5±1.9 *
142.6±1.5 *
2.78±0.16
4.31±0.22 *
6.16±0.13 *
75.2±4.1
105.4±3.4 *
140.3±3.2 *
24.9±1.7
35.4±2.2 *
40.2±1.2 *
0.57±0.05
1.06±0.05 *
0.54±0.05 *

α1-blockade
80.9±1.5 †
83.8±1.4 *†
117.5±2.4 *†
2.96±0.21
4.48±0.22 *†
6.37±0.19 *†
89.8±5.3
119.6±3.4 *
159.9±10.1 *
29.5±2.4 †
40.6±2.6 *†
49.6±1.7 *†
0.58±0.04
1.08±0.07 *
0.58±0.07 *

Control
77.0±0.6 ‡
79.6±2.0 ‡
111.2±3.8 ‡
2.26±0.11 ‡
3.38±0.14 *‡
3.84±0.22 ‡
105.0±5.8
137.2±5.8 *
165.5±6.6 *
24.5±1.6
33.1±1.3 *
29.9±1.2 *‡
0.40±0.02 ‡
0.85±0.05 *‡
0.48±0.04 *‡

α1-blockade
71.1±1.6
72.3±1.0
105.3±3.8
2.53±0.13 †
4.00±0.17 *†
5.57±0.17 *†
102.0±4.0
139.6±6.0 *
173.6±5.0 *†
29.2±2.1 †
41.0±2.6 *†
48.0±2.2 *†
0.49±0.02 †
1.03±0.08 *†
0.57±0.06 *†

dP/dtmax
(mmHg/s)

Rest
Ex
MMA

1854±61
2030±93 *
2892±104 *

1827±69 †
2120±71 *†
3211±145 *†

792±20 ‡
911±57 *‡
1266±24 *‡

882±39
1064±53 *
1640±136 *†

dP/dtmin
(mmHg/s)

Rest
Ex
MMA

-1593±83
-1653±84
-2585±89 *

-1435±42
-1513±30 *
-2219±128 *

-786±31 ‡
-863±52 ‡
-1200±9 *‡

-882±56
-1033±32 †
-1521±89 *†

Values are means ± SE. MAP, mean arterial pressure; CO, cardiac output; HR, heart rate; NIVC, nonischemic vascular conductance; HLBF, hindlimb blood flow; dP/dtmax, maximal rate of left ventricular
pressure increase; dP/dtmin maximal rate of left ventricular relaxation. *p<0.05 vs. previous setting in same
experiment; † p<0.05 vs. control; ‡ p<0.05 vs. normal.

After induction of HF in the same animals, resting levels of MAP, CO, HLBF,
dP/dtmax and dP/dtmin were significantly lower.

Although CO, HR, NIVC, HLBF and
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ventricular contractility increased from rest to exercise, they were significantly lower
than normal exercising levels with the exception of HR.

Following metaboreflex

activation in HF animals, increases in MAP, CO, dP/dtmax and dP/dtmin were significantly
attenuated and there was vasoconstriction in the non-ischemic vasculature. Following
α1-adrenergic blockade, resting CO, HLBF and NIVC increased. From rest to exercise,
significant increases in CO, HR, NIVC, HLBF and ventricular contractility were
observed.

Muscle metaboreflex activation following α1-blockade in HF animals

significantly increased CO, HR, NIVC, dP/dtmax and dP/dtmin and these parameters were
significantly improved compared to metaboreflex responses in HF.
Discussion
The major new finding of this study is that muscle metaboreflex-induced
vasoconstriction of the ischemic active skeletal muscle is exaggerated in heart failure.
Previous studies have shown that metaboreflex-induced increase in MAP partially
restores blood flow to ischemic active muscle in healthy subjects. Whether the muscle
metaboreflex-induced increase in sympathetic activity causes vasoconstriction the
ischemic active muscle has been controversial (33, 54, 59). We recently showed that
metaboreflex activation during submaximal exercise induces α-mediated sympathetic
vasoconstriction within the ischemic active muscle, limiting the capability of
metaboreflex to restore blood flow to the muscle (36). In HF, the ability of the reflex to
increase CO is markedly limited and the metaboreflex-induced pressor response occurs
primarily via peripheral vasoconstriction. Inability to increase CO in HF limits restoration
of blood flow to the ischemic muscle and exaggerated vasoconstriction of ischemic
active muscle would further limit blood supply and enhance muscle ischemia. This
generates a positive feedback loop that potentially contributes to exercise intolerance in
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HF.
Metaboreflex responses in HF
Inasmuch as heightened coronary vasoconstriction limits the cardiac function
(15) and little increase in CO occurs in HF, mechanisms of muscle metaboreflex shift
from CO-mediated to peripheral vasoconstriction induced pressor response (16, 29, 58).
The limited CO increase in HF attenuates the rise in MAP and consequently, limits the
ability of metaboreflex to partially restore blood flow to the ischemic muscle.
Vasoconstriction of inactive beds plays a very small role in generating the pressor
response as blood flow to inactive beds constitutes only a small proportion of CO and
thereby, total vascular conductance (52). With active skeletal muscle comprising the
largest fraction of total vascular conductance, it is the only target vasculature for
vasoconstriction during metaboreflex activation capable of generating large pressor
responses.

This is the first study to show that metaboreflex-induced hindlimb

vasoconstriction is exaggerated in HF.

The vasoconstriction is abolished after α1-

blockade, indicating the sympathetic origin of the vasoconstriction.

In addition, α1-

blockade also markedly improved HLBF during free-flow exercise, revealing a potential
therapeutic target for exercise intolerance in HF.
If muscle metaboreflex activation induces sympathetically-mediated constriction
of the ischemic muscle from which it originates, active ischemic muscle is both the
origin and the target of the reflex. On the afferent side, metabolic accumulation in the
muscle stimulates group III/IV nerves and elicits the muscle metaboreflex which in turn
increases CO, redistributes blood flow and causes vasoconstriction of the ischemic
muscle on the efferent side. Vasoconstriction of the already ischemic muscle would
further limit the oxygen delivery to the muscle causing more ischemia and heightened
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metaboreflex activation. We previously showed that in normal subjects, metaboreflexinduced vasoconstriction of the ischemic active muscle acts as a limiting positive
feedback where afferent and efferent responses progressively become smaller and
plateau at an amplified response level (36). The slope of the relationship between
hindlimb resistance and HLBF in normal animals is -32.6 units compared to -97.9 units
after induction of HF. The slope value indicates that for every liter/min decrease in
HLBF, there is a 97.9 unit increase in hindlimb resistance. At the threshold level of
HLBF, a 97.9 mmHg/l/min increase in hindlimb resistance would cause 0.84 l/min fall in
HLBF if pressure remained constant.

This decrease in HLBF would cause further

ischemia and increase hindlimb resistance by 82.1 mmHg/l/min, which in turn would
reduce HLBF by 0.2 l/min and so forth. Thus, the stimulus and the response become
smaller with each cycle of positive feedback and will eventually reach a plateau.
Therefore, muscle metaboreflex activation in HF is still a limiting positive feedback reflex
albeit with a markedly amplified slope than in normal subjects. Previous studies have
shown a larger vasoconstriction of the peripheral vasculature with heavier workloads (6,
30). With increase in workload, the metaboreflex could easily convert into a run-away
feedback loop where the stimulus and the response get larger with each cycle, rapidly
reaching infinite resistance. Indeed, the large vasoconstriction we observed in HF is
perilously close to a level in which the increase in resistance would elicit a fall in flow
greater than that which engaged the reflex. The result would be a rapidly escalating
response leading to total vasoconstriction.
Mechanisms for heightened SNA in HF
Heightened SNA and impaired muscle blood flow in HF could result from various
different pathways and vascular factors. The arterial baroreflex buffers about one-half
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of the metaboreflex-induced pressor response in normal animals by restraining
peripheral vasoconstriction (40). In HF, the strength of baroreflex is impaired at both
rest (61) and during exercise (38). The reduced baroreflex buffering of the metaboreflex
potentially contributes to elevated SNA and peripheral vasoconstriction in HF.
Respiratory muscles play an important role in muscle metaboreflex activation during
dynamic exercise (64). Low CO in HF causes hypoperfusion of all tissues including
respiratory muscles. Increased exertion of the respiratory muscles during exercise in HF
likely causes enhanced afferent activation augmenting the metaboreflex-induced
responses. A recent study also implicated aberrant activation of cardiac sympathetic
afferents in HF which contributes to elevated SNA at rest (92).

Enhanced arterial

chemoreflex activation has also been shown in HF (83). Neurogenic vasoconstriction
of the active skeletal muscle is attenuated by the metabolic by-products in the muscle,
termed functional sympatholysis (63). However, functional sympatholysis is impaired in
pathophysiological states such as HF, hypertension, etc. (85, 90). Moreover, impaired
endothelium-mediated vasodilation and elevated circulating levels of catecholamines,
vasopressin, angiotensin II, etc. could further increase the peripheral vasoconstriction in
HF subjects (22, 30). Some studies have shown reduced oxidative type I fibers and
increased glycolytic type II b fibers in HF subjects which could reduce their exercise
capacity and lead to exercise intolerance (23, 82).
Perspectives
The muscle metaboreflex is not tonically active at mild workload in canines as
HLBF must be reduced below threshold flow before any metaboreflex responses are
observed. Due to lower perfusion in HF, metaboreflex threshold during mild exercise is
achieved earlier and likely contributes to heightened vasoconstriction with metaboreflex
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activation in HF as workload increase and tonic activity of the reflex ensues. (6). To
what extent the muscle metaboreflex approaches run-away positive feedback levels
with higher intensity exercise is unknown. Furthermore, there is evidence that reflexes
arising from skeletal muscle afferents are tonically active in humans during even
relatively mild exercise (2, 68). The exaggerated vasoconstriction within the ischemic
active muscle together with limited metaboreflex restoration of the blood flow to the
ischemic muscle likely impairs the ability to exercise and contributes to exercise
intolerance in HF.
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CHAPTER 5 - MUSCLE METABOREFLEX AND ARTERIAL BAROREFLEX: ACTION,
INTERACTION AND CONTROL OF BLOOD FLOW TO ACTIVE MUSCLE
Abstract
The muscle metaboreflex and arterial baroreflex regulate arterial pressure
through distinct mechanisms. Muscle metaboreflex activation (MMA) elicits a pressor
response virtually solely by increasing cardiac output (CO) while baroreceptor unloading
increases mean arterial pressure (MAP) primarily through peripheral vasoconstriction.
We activated the muscle metaboreflex in chronically instrumented canines during
dynamic exercise (via graded reductions in hindlimb blood flow; HLBF) followed by
simultaneous baroreceptor unloading (via bilateral carotid occlusion; BCO).

We

hypothesized that simultaneous activation of both reflexes would result in an
exacerbated pressor response owing to both an increase in CO and vasoconstriction.
We observed that MMA caused a significant increase in MAP, heart rate (HR), CO, and
non-ischemic vascular conductance (NIVC; conductance of all vascular beds except the
hindlimb vasculature).

When followed by BCO during MMA, there were further

increases in MAP and HR however, NIVC decreased by ~25% indicating substantial
peripheral vasoconstriction. Although there was significant vasoconstriction within the
ischemic muscle itself, the remaining vasculature vasoconstricted to a greater extent,
thereby redirecting blood flow to the ischemic muscle. We conclude that baroreceptor
unloading during MMA induces preferential peripheral vasoconstriction to improve blood
flow to the ischemic active skeletal muscle.
Introduction
Insufficient oxygen delivery to the active skeletal muscle during exercise causes
accumulation of metabolites (e.g., hydrogen ions, adenosine, lactic acid, etc.) which

55
stimulate the group III and IV muscle afferents eliciting a reflex pressor response,
termed the muscle metaboreflex (1, 9, 35, 43, 65, 77). Muscle metaboreflex activation
during dynamic exercise significantly increases mean arterial pressure (MAP), cardiac
output (CO), heart rate (HR) and ventricular contractility which combined with enhanced
right atrial pressure maintains or slightly increases stroke volume (16, 32, 70, 71, 78,
88, 95). Although some regional vasoconstriction occurs with metaboreflex activation
during submaximal exercise (e.g., coronary, renal, forelimbs (3, 6, 13, 48, 49)), total
vascular conductance (TVC) is relatively unchanged (6, 17, 18, 29, 74). Thus, muscle
metaboreflex-induced pressor response during dynamic exercise occurs virtually solely
due to an increase in CO (6, 29, 55, 71, 78, 95).
At rest and during exercise the arterial baroreflex is the primary short-term
negative feedback reflex which maintains arterial pressure by regulating TVC and CO.
The arterial baroreflex primarily modulates TVC as little change in CO occurs during
steady state (11, 60, 79, 80, 91). Therefore, the muscle metaboreflex and the arterial
baroreflex regulate arterial pressure via two distinct mechanisms. Muscle metaboreflex
activation increases MAP primarily by increasing CO whereas arterial baroreflex
activation increases MAP primarily through peripheral vasoconstriction. As workload
increases, active skeletal muscle vasculature becomes an increasingly important target
for baroreflex-induced peripheral vasoconstriction (11).

We recently showed that

muscle metaboreflex activation induces sympathetic vasoconstriction within the
ischemic muscle thereby limiting the ability of the metaboreflex to improve muscle blood
flow (36). The interaction of the muscle metaboreflex and the arterial baroreflex has not
been well established, especially when these reflexes are coactivated. In this study, we
quantified the contribution of CO and TVC to the pressor response elicited by carotid
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baroreceptor unloading (via bilateral carotid occlusion; BCO) at rest, during mild
exercise and during muscle metaboreflex activation.

We investigated whether

concurrent activation of the two reflexes undergoes an additive, occlusive or facilitative
interaction. Since carotid baroreceptor unloading induces peripheral vasoconstriction,
to what extent the ischemic muscle vasoconstricts during concurrent activation of the
baroreflex and the muscle metaboreflex is unknown. Previous studies hypothesized
that increases in metabolic by-products in skeletal muscle during exercise reduces the
efficacy of sympathetic nerves to elicit vasoconstriction (63, 84). We hypothesized that
baroreceptor unloading during metaboreflex activation would still elicit substantial
systemic peripheral vasoconstriction even within the ischemic hindlimb. However, if
non-ischemic beds are more susceptible to neurogenic vasoconstriction, then there may
be redistribution of the available CO towards the ischemic muscle.
Methods
Experimental subjects
Eight adult mongrel canines (5 females, 3 males; 20-25 kg) were selected for the
study. All the procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of Wayne State University and complied with the National Institutes
of Health Guide to the Care and Use of Laboratory Animals.

All animals were

acclimatized to the laboratory surroundings and willing to run on a motor-driven
treadmill; no negative reinforcement techniques were utilized.
Surgical procedures
For each of the three surgical procedures, the animals were sedated with
acepromazine (0.2-0.5 mg/kg IM) and received preoperative analgesics [carprofen (4.4
mg/kg IV), buprenorphine (0.01-0.03 mg/kg IM) and fentanyl (50–125 µg/h (72h)
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transdermal delivery)]. Anesthesia was induced with ketamine and diazepam (5 mg/kg
IV and 0.2-0.3 mg/kg IV, respectively) and maintained with isoflurane gas (1–3%).
Cefazolin (antibiotic, 30 mg/kg IV) was administered pre- and postoperatively to avoid
acute postoperative infections. Animals were closely monitored postoperatively and
given buprenorphine (0.01-0.03 mg/kg IM) and acepromazine (0.2-0.3 mg/kg IV) as
needed. Cephalexin (antibiotic, 30 mg/kg (BID) PO) was administered prophylactically
for the entire term of the experimental protocol. The animals recovered for two weeks
after each surgery.
In the first surgical procedure, the thoracic cavity was opened via a left
thoracotomy (3rd/4th intercostal space) approach and the pericardium was cut to
expose the heart. A telemetry pressure transmitter (TA11 PA-D70, DSI) was tethered
subcutaneously at the height of the left ventricular apex and two intercostal spaces
caudal to the thoracotomy incision (n=5). The tip of the pressure transducer catheter
was inserted into the left ventricle and secured. A perivascular flow probe (20PAU,
Transonic Systems) was placed around the ascending aorta to measure CO. Pacing
wires were secured to the free wall of the right ventricle for studies unrelated to the
present study.

The pericardium was reapproximated and all wires were tunneled

subcutaneously and exteriorized between the scapulae.

The chest was closed in

layers.
In the second surgical procedure, the abdominal aorta and left renal artery were
exposed through a left retroperitoneal approach. Perivascular flow probes (Transonic
Systems) were positioned around the terminal aorta (10PAU) and the left renal artery
(4PSB) to measure hindlimb blood flow (HLBF) and renal blood flow (RBF),
respectively. All side branches of the terminal aorta between the iliac arteries and the
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aortic flow probe were ligated and severed. Two hydraulic occluders (8-10 mm, DocXS
Biomedical Products) were placed around the terminal aorta distal to the flow probe. A
19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was inserted into a side branch of
the aorta cranial to the flow probe to measure systemic arterial pressure. A second
catheter was inserted into a side branch of the aorta caudal to the occluders to measure
arterial pressure below the occluders (femoral arterial pressure; FAP).

When the

catheterization of a caudal aortic branch was not possible, a side branch of the femoral
artery was catheterized in the third procedure.

All instrumentation was tunneled

subcutaneously and exteriorized between the scapulae and the abdomen was closed in
layers.
In the third surgical procedure, a hydraulic occluder (4-6 mm, DocXS Biomedical
Products) was placed around each common carotid artery via a midline neck incision in
order to perform bilateral carotid occlusion (BCO).

The right jugular vein was

catheterized (n=3) for studies unrelated to the present study. Instrumentation was
tunneled subcutaneously and exteriorized between the scapulae and the neck was
closed in layers.
Data acquisition
Before each experiment, animals were brought into the laboratory and allowed to
roam freely and acclimate for ~10-20 minutes, before being directed onto the treadmill.
The CO, RBF, and HLBF flow probe cables were connected to flow meters (TS420,
Transonic Systems) and the left ventricular implant transmitter was turned on to collect
data via telemetry (DSI). The arterial catheters were aspirated, flushed and connected
to pressure transducers (Transpac IV, ICU Medical). All hemodynamic variables, in
addition to MAP (calculated) and HR (triggered by the CO signal), were monitored as
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real-time waveforms by a data acquisition system (LabScribe, iWorx) and recorded for
subsequent off-line analysis.
Experimental procedures
All experiments were performed after the animals had fully recovered from
surgery (i.e., were active and of good appetite). Each experiment began with the animal
standing still on the treadmill until all resting hemodynamic data were observed to be
stable (~ 5-10 min). Three different experimental protocols were used: BCO at rest,
BCO during exercise and BCO with muscle metaboreflex activation.

In the first

experimental protocol, steady state data collection at rest was followed by BCO
performed by inflating the carotid occluders for 2 min while the animals were standing
on the treadmill. BCO during exercise: After collecting resting steady state data, the
treadmill was turned on and gradually increased to a speed of 3.2 kph at 0% grade (mild
exercise). The animals exercised for 5-10 min followed by BCO for 2 min during the
same workload. BCO during metaboreflex activation: After collecting steady state data
during rest and mild exercise, muscle metaboreflex was engaged via graded reductions
in HLBF (via partial inflation of terminal aortic occluders) during mild exercise. Each
level of vascular occlusion was maintained until all parameters had reached steady
state (~ 3-5 min). After the steady state for maximal metaboreflex activation, BCO was
performed for 2 min. The large increase in MAP with BC during metaboreflex activation
would force more flow through the hindlimb occluders which would lessen metaboreflex
activation, therefore the occluder resistance was increased to keep HLBF constant.
Data analysis
MAP, FAP, CO, HR, RBF, left ventricular pressure and HLBF were continuously
recorded during each experimental procedure. Other hemodynamic parameters were
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calculated during off-line data analysis (e.g., dP/dtmax, dP/dtmin, total vascular
conductance (TVC), renal vascular conductance (RVC), hindlimb vascular conductance
(HVC) and conductance of all vascular beds except the hindlimbs (non-ischemic
vascular conductance; NIVC). TVC, RVC, HVC and NIVC were calculated as CO/MAP,
RBF/MAP, HLBF/FAP and (CO-HLBF)/MAP, respectively. Due to technical difficulties,
dP/dtmax and dP/dtmin values were only calculated in five animals. One minute averages
of all variables were taken during steady-state at rest, free-flow exercise, muscle
metaboreflex activation and BCO. Mean values were averaged across all animals to
obtain the sample mean of the study.
Partial reductions in HLBF by using the hydraulic occluders cause MAP to
increase passively (MAPpassive) (6, 95).

Thus, the pressor response observed with

metaboreflex activation in our experiments is a combination of a reflex increase in MAP
(MAPactive) and the passive effect of the occluder.

MAPpassive was calculated as

COEX/(NIVCEX + HVCObserved), where the subscript EX indicates free-flow exercise
levels. MAPactive, the increase in MAP due to reflex activation, was calculated by
subtracting MAPpassive from the observed MAP values.
The percent contributions of CO and TVC to the baroreflex-induced pressor
response were calculated as follows:
∆ MAPTVC =

COPre
NIVCBCO + HVCBCO

% contribution of TVC =

_

COPre
NIVCPre + HVCPre

∆ MAPTVC
x 100
∆ MAPObserved

∆ MAPCO = (COBCO - COPre)
NIVCPre + HVCPre
% contribution of CO =

∆ MAPCO
x 100
∆ MAPObserved

where the subscripts BCO and Pre indicate BCO and pre-BCO levels, respectively.
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Since all of the pressor response to BCO during muscle metaboreflex activation was
due to peripheral vasoconstriction, the percent contribution of TVC was calculated as
100 – percent contribution of CO. BCO during metaboreflex activation causes a large
pressor response which leads to an increase in HLBF which would in turn change the
stimulus for muscle metaboreflex. Thus, HLBF was kept constant by increasing the
occluder resistance. We calculated the predicted rise in HLBF, if there was no increase
in occluder resistance, as (MAP during BCO)/(hindlimb resistance during BCO +
occluder resistance during metaboreflex activation).
Statistical analysis
All hemodynamic data are reported as means ± SE. An α-level of P < 0.05 was
used to determine statistical significance. Paired t-tests were performed to compare the
responses between rest and BCO during rest. Averaged responses for each animal
were analyzed with Systat software (Systat 11.0). A one-way ANOVA with repeated
measures was used to compare hemodynamic data for time effect. In the event of a
significant time effect, a C-matrix test for simple effects was performed.
Results
Figure 5.1 shows representative hemodynamic responses evoked by BCO during
rest, mild exercise and muscle metaboreflex activation in one animal. BCO at rest
resulted in a large pressor response with little change in CO and a large decrease in
NIVC, indicating that the pressor response was mediated predominately by peripheral
vasoconstriction. From rest to exercise, there was moderate increase in CO, NIVC and
HLBF. BCO during mild exercise increased MAP again predominately due to a large
decrease in NIVC. Small increases in CO and HLBF also occurred. With metaboreflex
activation during mild exercise, the large pressor response is occurred via a large
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increase in CO as there was a modest increase in NIVC.

Baroreceptor unloading

during muscle metaboreflex activation caused a further large increase in MAP. This
pressor response was mediated via peripheral vasoconstriction inasmuch as a large
decrease in NIVC as well as a small decrease in CO occurred. In order to keep the
metaboreflex stimulus constant during concurrent activation of baroreflex and
metaboreflex, HLBF was maintained constant by manually increasing the resistance of
the hydraulic occluders on the terminal aorta.
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Figure 5.1. Data from one animal showing mean arterial pressure, cardiac output, nonischemic vascular conductance and hindlimb blood flow in response to bilateral carotid
occlusion (BCO) during rest (left panel), exercise (Ex; middle panel) and muscle
metaboreflex activation (MMA; right panel).
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Figure 5.2. Average hemodynamic data during (A) rest (open bars) and bilateral carotid
occlusion (BCO) at rest (grey bars); (B) rest, mild exercise (Ex; hatched bars) and BCO
during Ex (grey bars); (C) rest, Ex, muscle metaboreflex activation (MMA; crosshatched bars) and BCO during MMA (solid bars). * p<0.05 vs. previous setting.
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Figure 5.2 shows average values of MAP, CO, HR, NIVC, RVC, dP/dtmax and
dP/dtmin during BCO at rest, during mild exercise and metaboreflex activation.
BCO at rest.

Carotid baroreceptor unloading at rest resulted in a significant

increase in MAP with small but significant increases in CO, HR, dP/dtmax and dP/dtmin.
Large significant decreases in NIVC and RVC indicates that the pressor response was
primarily caused by peripheral vasoconstriction.
BCO during exercise. From rest to exercise, there were a significant increases in
NIVC, CO, HLBF, and HR. BCO during exercise resulted in significant increases in
MAP, CO, HR, dP/dtmax and dP/dtmin and significant decreases in NIVC and RVC.
BCO during metaboreflex activation. NIVC, CO, and HR increased significantly
from rest to exercise. Muscle metaboreflex activation (via partial reduction in HLBF)
caused significant increases in MAP, NIVC, CO, HR, dP/dtmax and dP/dtmin while RVC
decreased significantly. Coactivation of baroreflex and muscle metaboreflex resulted in
a further significant increases in MAP, HR, dP/dtmax and dP/dtmin and significant
decreases in NIVC, CO and RVC.
Figure 5.3 shows the hemodynamic changes in hindlimb vascular conductance
and HLBF during BCO at rest, during mild exercise and muscle metaboreflex activation.
During BCO at rest, HVC significantly decreased indicating vasoconstriction in the
hindlimb vasculature. HLBF increased despite the vasoconstriction due to the increase
in MAP.

From rest to exercise, both HVC and HLBF increased significantly.

In

response to BCO during exercise, there was a large decrease in HVC and HLBF again
increased somewhat HLBF. Muscle metaboreflex was activated during mild exercise by
reducing HLBF to ~40% of the value observed during free-flow exercise. We have
recently shown that initial reductions in HLBF cause vasodilation in the hindlimb, but
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when the metaboreflex is engaged, vasoconstriction ensues which brings HVC back
towards the levels observed prior to hindlimb ischemia (37). With BCO during muscle
metaboreflex

activation,

there

is

a

significant

decrease

in

HVC

indicating

vasoconstriction. The HLBF during the co-activation of both reflexes was kept constant
by increasing the hindlimb occluder resistance. If there was no change in the occluder
resistance, HLBF would have increased significantly (predicted HLBF).
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Figure 5.3. Average hindlimb vascular conductance and hindlimb blood flow responses
during (A) rest (open bars) and bilateral carotid occlusion (BCO) at rest (grey bars); (B)
rest, mild exercise (Ex; hatched bars) and BCO during Ex (grey bars); (C) rest, Ex,
muscle metaboreflex activation (MMA; cross-hatched bars) and BCO during MMA (solid
bars). The bar inscribed with P indicates the predicted HLBF during coactivation of two
reflexes.* p<0.05 vs. previous setting.
Figure 5.4 shows the absolute changes in the cardiovascular parameters evoked
by BCO at rest, during mild exercise and during metaboreflex activation in eight normal
animals. The pressor responses evoked by BCO at rest, during exercise and during
metaboreflex activation were not different from each other.

Changes in CO, HR,

dP/dtmax, dP/dtmin, RVC and HLBF were similar during BCO at rest and BCO during mild
exercise. However, decreases in NIVC and HVC were significantly larger with BCO
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Figure 5.4. The absolute changes (∆) in hemodynamic values from rest to bilateral
carotid occlusion (BCO) during rest (open bars), from exercise (Ex) to BCO during Ex
(hatched bars) and from muscle metaboreflex activation (MMA) to BCO during MMA
(filled bars). * p<0.05 vs. previous setting. MAP, mean arterial pressure; CO, cardiac
output; HR, heart rate; dP/dtmax, maximal rate of change in left ventricular pressure;
dP/dtmin, minimal rate of change in left ventricular pressure; RVC, renal vascular
conductance; NIVC, non-ischemic vascular conductance; HVC, hindlimb vascular
conductance; HLBF, hindlimb blood flow.
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during exercise than BCO at rest. With coactivation of baroreflex and metaboreflex,
there was a large increase in HR with further improvement in contractility and lusitropy,
however, CO decreased slightly. While the vasoconstriction of non-ischemic vascular
beds in response to coactivation of reflexes was similar to that during BCO with
exercise, the reduction in RVC and HVC was significantly smaller than with BCO during
exercise. The predicted increase in HLBF during coactivation of reflexes was similar to
the increase in HLBF seen in response to BCO during mild exercise.
To investigate the mode of interaction between arterial baroreflex and muscle
metaboreflex (i.e., additive, facilitative or occlusive interaction), the observed responses
during coactivation of baroreflex and metaboreflex activation were compared to the sum
of metaboreflex-induced and BCO-induced responses during exercise.

Figure 5.5

shows absolute changes in hemodynamic parameters in response to BCO during
exercise, muscle metaboreflex activation, the sum of muscle metaboreflex-induced and
BCO-induced responses during exercise and the observed hemodynamic changes in
response to BCO during metaboreflex activation.

The sum of individual reflex

responses and the observed responses during coactivation were not different for MAP,
NIVC and ventricular function, indicating an additive interaction. However, the observed
responses during coactivation of the two reflexes were smaller for CO and RVC
indicating that for these parameters the arterial baroreflex and the muscle metaboreflex
summate as occlusive interaction.

On the contrary, coactivation responses were

significantly higher than the sum of individual responses for HR, indicating a facilitative
interaction.
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Figure 5.5. Absolute changes (∆) in cardiovascular responses evoked by bilateral
carotid occlusion (BCO) during mild exercise (hatched bars), muscle metaboreflex
activation (MMA; cross-hatched bars), sum of individual MMA and BCO responses
during exercise (SUM; filled bars) and observed combined effect of the MMA and BCO
during MMA (OBS; open bars). ‡ p<0.05 vs. calculated sum of reflex-induced response
during MMA and BCO during exercise.
Figure 5.6 shows the relative contribution of CO and TVC in mediating the rise in
MAP in response to BCO during rest, BCO during exercise, muscle metaboreflex
activation and BCO during metaboreflex activation. Pressor response to BCO during
rest and exercise was primarily due to peripheral vasoconstriction as there is only a
small contribution of CO. Muscle metaboreflex-induced pressor response was virtually
solely driven by increase in CO as there is negative contribution of TVC.

Pressor

response with BCO during metaboreflex activation was solely due to the increase in
peripheral vasoconstriction.
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Figure 5.6. Percent contribution of cardiac output (CO; open bars) and total vascular
conductance (TVC; filled bars) to pressor response evoked by bilateral carotid occlusion
(BCO) at rest, BCO during exercise, muscle metaboreflex activation (MMA) and BCO
during MMA. * p<0.05 vs. contribution of CO.
Discussion
This is the first study to investigate the strength and mechanisms of the muscle
metaboreflex and arterial baroreflex when activated separately and concurrently, and
the effect of this interaction on ventricular function, cardiac output and the distribution of
total systemic peripheral blood flow.

We found that the pressor responses to

baroreceptor unloading and metaboreflex activation were additive, however the
mechanisms mediating each pressor response were diametrically opposite: arterial
baroreflex

activation

primarily

induces

peripheral

vasoconstriction

whereas

metaboreflex activation primarily raises CO. When activated concurrently, profound
pressor responses occur due to substantial vasoconstriction coupled with increased
CO.

Further, we found that baroreceptor unloading during metaboreflex activation

causes vasoconstriction even within the ischemic active skeletal muscle. However, the
vasoconstriction in all other vascular beds combined is greater than that in the ischemic
muscle which thereby causes redistribution of cardiac output towards the ischemic
beds.

This shift of total systemic blood flow towards the ischemic muscle during

combined baroreflex and metaboreflex activation acts to attenuate the level of
metaboreflex stimulation.
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Muscle metaboreflex and arterial baroreflex interaction
Reflexes interact in three different ways: additive interaction, where the
coactivation responses equal the sum of reflex responses when activated individually;
facilitative interaction, where responses during coactivation of two reflexes are larger
than the sum of individual reflex responses; occlusive interaction, where the
coactivation responses are smaller than the sum of individual reflex responses. We
observed that the pressor response evoked by BCO during metaboreflex activation was
similar to the sum of metaboreflex-induced and BCO-induced pressor response during
exercise, indicating additive interaction between the two reflexes. The same conclusion
holds for ventricular function and NIVC responses. However, CO and RVC responses
exhibit occlusive interaction and HR responses undergo facilitative interaction upon
coactivation of the two reflexes. Therefore, the interaction between arterial baroreflex
and muscle metaboreflex when activated simultaneously is intimately dependent on the
hemodynamic parameter being investigated.
Regulation of skeletal muscle blood flow
During progressive dynamic exercise the skeletal muscle vasculature becomes
an increasingly important target vascular bed mediating the rise in arterial pressure
during in response to baroreceptor unloading (11, 60). We recently showed that muscle
metaboreflex activation induces sympathetic vasoconstriction within ischemic active
muscle thereby, limiting the ability of the metaboreflex to improve muscle blood flow
(36). BCO during metaboreflex activation causes further vasoconstriction within the
ischemic hindlimb vasculature, although the decrease in HVC during coactivation of two
reflexes is significantly smaller than that observed in response to BCO during normal
exercise. One of the plausible causes for this smaller vasoconstriction in the hindlimb
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vasculature could be functional sympatholysis, a phenomenon described as attenuated
sympathetic vasoconstriction of the active skeletal muscle due to metabolic
accumulation in the muscle (63, 84). The large increase in MAP in response to BCO
during metaboreflex activation increases HLBF despite the vasoconstriction of hindlimb
vasculature. Therefore, in order to maintain the same metaboreflex stimulus during
coactivation of the reflexes, HLBF was kept constant by increasing the occluder
resistance. If there was no change in the occluder resistance, the HLBF (predicted
HLBF) would have increased significantly with the rise in arterial pressure driving more
flow through the occluder resistance as well as the hindlimb vascular resistance. With a
decrease in CO and vasoconstriction in the hindlimb vasculature during coactivation of
the reflexes, the only way HLBF could have increased is by a larger vasoconstriction of
the non-ischemic vasculature than the ischemic hindlimb vasculature. This preferential
vasoconstriction in the non-ischemic vasculature redirects blood flow to the hindlimbs
which thereby increases HLBF. This rise in HLBF would act to actually attenuate the
metaboreflex activation. Interestingly, we calculated that the predicted HLBF during
coactivation of the two reflexes would have virtually restored HLBF almost back to the
metaboreflex threshold level of
HLBF (Figure 5.7).

Figure
5.7.
Mean
arterial
pressure and hindlimb blood flow
during
muscle
metaboreflex
activation (MMA; filled circles)
followed by bilateral carotid
occlusion (BCO) during MMA
(open circles) in an experiment.
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Where does vasoconstriction occur?
Previous studies have shown that active skeletal muscle becomes the primary
target bed for baroreflex-induced peripheral vasoconstriction with increasing exercise
intensity (11). We observed that although BCO during metaboreflex activation caused
vasoconstriction within ischemic active muscle, blood flow to the ischemic muscle would
still have improved (given that occluder resistance was not changed) due to a larger
vasoconstriction in other vascular beds. Since active skeletal muscle constitutes the
largest proportion of TVC during exercise, the preferential vasoconstriction during
coactivation of reflexes most likely occurs in active skeletal muscle other than the
hindlimb.

Although there is some vasoconstriction of inactive beds such as renal

vasculature during coactivation of baroreflex and muscle metaboreflex, inactive beds do
not have much potential to increase MAP or redirect blood flow to other vasculatures
(11, 52). In the present study, the RVC responses underwent occlusive interaction
upon coactivation of baroreflex and muscle metaboreflex.
Perspectives and significance
In normal individuals, metaboreflex activation causes large increases in CO and
MAP which in turn increase blood flow and oxygen delivery to the active vascular beds.
The arterial baroreflex buffers the metaboreflex pressor response by about 50% by
attenuating peripheral vasoconstriction (40). In conditions such as heart failure, where
increases in CO become limited, the only mechanism to increase MAP is via peripheral
vasoconstriction. Inasmuch as the strength of arterial baroreflex is impaired in heart
failure (38, 61), this would lessen the ability of arterial baroreflex to attenuate peripheral
vasoconstriction induced by metaboreflex activation, leading to markedly large
increases in vascular sympathetic tone, particularly the active ischemic muscle.
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Moreover, baroreceptor unloading during metaboreflex activation leads to larger
vasoconstriction of the non-ischemic vasculature causing improvement in HLBF. In
heart failure, this increase in HLBF could be attenuated, abolished, or possibly even
reduce HLBF which could elicit a rampant positive feedback spiral where the baroreflex
further engages the metaboreflex leading to a veritable sympathetic storm.

It is

unknown whether these interactions contribute to the often massive peripheral
vasoconstriction which occurs during exercise in heart failure and likely contribute to
exercise intolerance in these patients.
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CHAPTER 6 - INTERACTION BETWEEN ARTERIAL BAROREFLEX AND MUSCLE
METABOREFLEX IS ALTERED IN HEART FAILURE
Abstract
Previous studies have shown that heart failure (HF) alters the strength and
mechanisms of muscle metaboreflex and arterial baroreflex during dynamic exercise.
Muscle metaboreflex activation (MMA) in normal individuals increases mean arterial
pressure (MAP) virtually solely by an increase in cardiac output (CO) whereas in HF,
metaboreflex-induced pressor response occurs via peripheral vasoconstriction.

The

pressor response evoked by baroreceptor unloading in normal subjects occurs primarily
through peripheral vasoconstriction and this pressor response is blunted in HF.
However, the interaction between the two reflexes when activated simultaneously
during dynamic exercise in HF is unknown. We activated the muscle metaboreflex in
chronically instrumented canines during mild exercise (via graded reductions in hindlimb
blood flow; HLBF) followed by baroreceptor unloading (via bilateral carotid occlusion;
BCO) before and after induction of HF. We hypothesized that coactivation of both
reflexes in HF would cause a smaller increase in MAP and a larger vasoconstriction of
the ischemic hindlimb vasculature which would result in attenuated restoration of blood
flow to the ischemic muscle observed in normal. We observed that BCO during MMA
increases MAP by substantial vasoconstriction of all vascular beds including the
ischemic active muscle. All cardiovascular responses with the exception of ventricular
function exhibit occlusive interaction in response to baroreceptor unloading during MMA
in HF. We conclude that vasoconstriction of ischemic active skeletal muscle during
coactivation of both reflexes attenuates the restoration of HLBF.
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Introduction
Stimulation of skeletal muscle afferents by metabolites, such as hydrogen ions,
lactic acid, diprotonated phosphate, etc., that accumulate in the exercising muscle elicits
a large pressor response, termed the muscle metaboreflex (1, 9, 35, 65, 77). Muscle
metaboreflex activation significantly increases mean arterial pressure (MAP), cardiac
output (CO), heart rate (HR), ventricular contractility and right atrial pressure (16, 32,
43, 70, 71, 88, 95).

During submaximal exercise, muscle metaboreflex-induced

increase in MAP occurs virtually solely due to an increase in CO as there is little, if any,
peripheral vasoconstriction (6, 17, 18, 29, 71, 74, 78).

Another blood pressure

regulating reflex is the arterial baroreflex, a negative feedback reflex that maintains
arterial pressure primarily by modulating peripheral vascular tone (11, 60, 79, 80, 91).
Thus, the muscle metaboreflex and the arterial baroreflex regulate arterial pressure via
two distinct mechanisms; muscle metaboreflex activation has a stronger control over
cardiac sympathetic activity and increases MAP by increasing CO whereas arterial
baroreflex activation has a stronger control over peripheral sympathetic activity and
increases MAP primarily through peripheral vasoconstriction.
In heart failure (HF), the strength and mechanisms of both muscle metaboreflex
and arterial baroreflex are altered (29, 38, 39, 51, 81). Impaired baroreflex sensitivity in
HF results in a smaller increase in MAP in response to carotid hypotension at rest (61,
93, 94) and during exercise (38, 39).
metaboreflex

activation

elicits

a

With limited CO reserve in HF, muscle

pressor

response

primarily

via

peripheral

vasoconstriction (14, 16, 29). In normal subjects, baroreceptor unloading during muscle
metaboreflex activation showed diverse interactions between different variables; MAP,
NIVC and ventricular function were additive; CO and RVC were occlusive and HR
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responses were facilitative. Moreover, a larger preferential vasoconstriction of the nonischemic vascular beds redirected blood flow to the ischemic muscle increasing HLBF.
In this study we investigate whether the interaction between the two reflexes when
activated simultaneously is altered in HF. We further studied the effect of coactivation
of reflexes on ischemic active muscle in HF and whether there is any restoration of
blood flow to the ischemic muscle.
Methods
Experimental subjects
All procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of Wayne State University and complied with the National Institutes
of Health Guide to the Care and Use of Laboratory Animals. Five adult mongrel canines
(20-25 kg; 1 male, 4 females) were selected for the study.

The animals were

acclimatized to the laboratory surroundings and exercised voluntarily during
experimentation; no negative reinforcement techniques were utilized.
Surgical procedures
The surgical procedures and medications used have been previously described
(36). Briefly, a 20-mm flow transducer was placed around the aortic root to measure
cardiac output (CO). A telemetry pressure transmitter was tethered subcutaneously and
its tip was inserted into the left ventricle to measure left ventricular pressure.

3-4

stainless steel pacing wires (0-Flexon) were secured to the right ventricular free wall.
Blood flow transducers was placed around the terminal aorta and the left renal artery to
measure hindlimb blood flow (HLBF) and renal blood flow (RBF), respectively. Two
hydraulic occluders were placed around the terminal aorta distal to the flow probe to
reduce HLBF. Arterial catheters were placed to measure systemic arterial pressure and
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femoral arterial pressure (FAP). Hydraulic occluders were also placed around common
carotid arteries to perform bilateral carotid occlusion (BCO). The animals recovered for
at least two weeks after each surgery.
Data acquisition
Before each experiment, the animals acclimated to the laboratory for ~10-20
minutes, following which they were directed onto the treadmill. The arterial catheters
were aspirated, flushed and connected to pressure transducers (Transpac IV, ICU
Medical), the flow probe cables were connected to flow meters (TS420, Transonic
Systems) and the left ventricular telemetry implant was turned on. All hemodynamic
variables were monitored as real-time waveforms by LabScribe2 data acquisition
system (iWorx) and recorded for off-line analysis.
Experimental procedures
Three different experimental protocols were used: BCO at rest, BCO during
exercise and BCO during muscle metaboreflex activation. BCO at rest: Steady state
data at rest were collected while the animal stood still on the treadmill.

This was

followed by BCO performed by inflating the carotid occluders for 2 minutes. BCO during
exercise: After collecting resting steady state data, the treadmill speed was gradually
increased to 3.2 kph at 0% grade (mild exercise).

The animals exercised until all

hemodynamic data were stable (~5-10 minutes) followed by BCO for 2 minutes during
the same workload. BCO during muscle metaboreflex activation: After collecting steady
state data at rest and during mild exercise, HLBF was gradually reduced to ~40% of
free-flow exercising levels (via partial inflations of the terminal aortic occluders) to
activate the muscle metaboreflex. Once steady state for muscle metaboreflex activation
was achieved and data were recorded, BCO was performed for 2 minutes. The large
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increase in MAP with BCO during metaboreflex activation caused an increase in HLBF
which in turn alters the metaboreflex stimulus.

Thus, HLBF was kept constant by

increasing the occluder resistance. After completion of experiments in normal animals,
rapid ventricular pacing at the rate of 220-240 beats/min was used to induce HF in the
same animals. All three experimental protocols were repeated in HF.
Data analysis
MAP, FAP, CO, HLBF, RBF, heart rate (HR; triggered from CO signal) and left
ventricular pressure (LVP) were continuously recorded during each experiment. Other
hemodynamic parameters were calculated during off-line data analysis (e.g., dP/dtmax,
dP/dtmin, total vascular conductance (TVC), renal vascular conductance (RVC), hindlimb
vascular conductance (HVC) and conductance of all vascular beds except the hindlimbs
(non-ischemic vascular conductance; NIVC). dP/dtmax and dP/dtmin were calculated as
the maximal rate of rise and fall in LVP, respectively. Due to technical difficulties, these
values were only calculated in four animals.

Vascular conductance for different

vascular beds were calculated as follows: TVC = CO/MAP, RVC = RBF/MAP, HVC =
HLBF/FAP and NIVC = (CO-HLBF)/MAP. One minute averages of all variables were
taken during steady-state at rest, BCO at rest, mild exercise, BCO during mild exercise,
muscle metaboreflex activation and BCO during metaboreflex activation. Mean values
were averaged across all animals to obtain the sample mean of the study. The pressor
response observed with metaboreflex activation in our experiments is a combination of
a reflex increase in MAP due to metaboreflex activation (MAPActive) and the passive
increase in MAP solely due to the mechanical effect of terminal aortic occluders
(MAPPassive).

MAPPassive was calculated as COEX/(NIVCEX + HVCObserved), where the

subscript EX indicates free-flow exercise level (6, 95). MAPActive was calculated by
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subtracting the passive increase in MAP from the observed MAP values at maximal
metaboreflex activation. HLBF during coactivation of the two reflexes was kept constant
by increasing the occluder resistance. We calculated the HLBF if there was no increase
in occluder resistance (predicted HLBF) as (MAP during BCO)/(hindlimb vascular
resistance during BCO + occluder resistance during metaboreflex activation).
Statistical analysis
All hemodynamic data are reported as means ± SE. An α-level of P<0.05 was
used to determine statistical significance. Average responses for each animal were
analyzed with Systat software (Systat 11.0). Two-way ANOVA with repeated measures
was used to compare hemodynamic data for time and/or condition effect. In the event
of a significant time-condition interaction, a C-matrix test for simple effects was
performed.
Results
Figure 6.1 shows average hemodynamic responses evoked by BCO at rest
before and after induction after HF. Carotid baroreceptor unloading at rest caused a
significant increase in MAP, CO and HR. After induction of HF, resting MAP and CO
were significantly lower and resting HR was significantly higher. BCO at rest elicited
large increases in MAP and HR in HF, however the magnitude of pressor response was
significantly lower and HR response was markedly higher than in normal. The small but
significant increase in CO observed in normal was abolished in HF. For NIVC, RVC,
HVC, dP/dtmax and dP/dtmin, there was a significant effect of BCO and HF.
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6.1.
Average
values for cardiovascular
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rest
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Average cardiovascular responses to BCO during exercise before and after
induction of HF are shown in Figure 6.2. From rest to mild exercise, there was a
moderate increase in CO, HR, NIVC and HVC. BCO during mild exercise resulted in
large increases in MAP, CO, HR and a decrease in HVC.

After induction of HF,

responses to mild exercise were similar to those in normal animals but with attenuated
resting and exercise levels of MAP, CO and HVC. With BCO during exercise in HF,
there was a significant increase in MAP and HR with no change in CO and a decrease
in HVC. There was a significant settings and HF effect on NIVC, RVC, dP/dtmax and
dP/dtmin responses.
Figure 6.3 shows the average hemodynamic changes in response to BCO during
muscle metaboreflex activation before and after induction of HF. Muscle metaboreflex
activation during mild exercise elicited significant increases in MAP, CO, NIVC, dP/dtmax
and dP/dtmin. With BCO during metaboreflex activation, there was further large increase
in MAP and ventricular function with significant decreases in CO and NIVC. Statistical
analysis showed a significant settings effect on HR, RVC and HVC in normal. After
induction of HF, muscle metaboreflex activation caused substantial increases in MAP
and ventricular function but the responses are significantly attenuated compared to
normal. The increase in CO observed in normal animals was abolished after induction
of HF and there was a significant vasoconstriction of non-ischemic vasculature. BCO
during metaboreflex activation resulted in a large pressor response, vasoconstriction of
non-ischemic vascular beds, improvement in ventricular function, however, these
responses were markedly lower than in normal. There was a significant effect of HF
and settings effect on HR, RVC and HVC responses.
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Figure 6.4 shows average cardiovascular responses when the arterial baroreflex
and the muscle metaboreflex were activated separately and concurrently.

To

investigate whether the interaction between the two reflexes is altered in HF, the
observed responses during coactivation of both reflexes in HF were compared to the
sum of metaboreflex-induced and BCO-induced responses during exercise in HF. In
healthy animals, MAP, NIVC and ventricular function responses displayed an additive
interaction, HR responses exhibited a facilitative interaction while CO and RVC
responses demonstrate an occlusive interaction.

After induction of HF, all

cardiovascular parameters exhibited occlusive interactions with the exception of
ventricular function responses, which displayed an additive interaction.
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Figure 6.5 shows HLBF responses during BCO at rest, during mild exercise and
muscle metaboreflex activation in normal animals and in same animals after induction of
HF. In normal animals, there was a significant increase in HLBF with BCO at rest and
during exercise which was abolished after induction of HF.

Although BCO during

muscle metaboreflex activation in normal individuals caused hindlimb vasoconstriction,
other vascular beds vasoconstricted more thereby, redirecting blood flow to ischemic
hindlimb vasculature. This significant increase in HLBF (predicted) during coactivation
of the two reflexes was substantially attenuated in HF.
Discussion
This is the first study to investigate the effect of HF on the interaction between
the muscle metaboreflex and the arterial baroreflex when activated concurrently. We
found that although baroreceptor unloading during metaboreflex activation in HF causes
a large pressor response via peripheral vasoconstriction, the rise in MAP is significantly
attenuated compared to normal. Peripheral vasoconstriction occurs in all vascular beds
including the ischemic active skeletal muscle. In normal animals, vasoconstriction in
non-ischemic vasculature is greater than that in the ischemic muscle, partially restoring
blood flow to the ischemic beds. This restoration of blood flow to the ischemic muscle is
significantly attenuated in HF.
Muscle metaboreflex and arterial baroreflex interaction
As previously shown, the interaction between arterial baroreflex and muscle
metaboreflex when activated simultaneously is dependent on the hemodynamic
parameter being investigated. Our results agree with the previous study as MAP, NIVC
and ventricular function responses during coactivation of two reflexes exhibit additive
interactions, CO and RVC responses were occlusive and HR responses exhibited
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facilitative interaction.

However, all the hemodynamic responses except ventricular

function converted to occlusive interactions after induction of HF. Although significantly
attenuated in HF, dP/dtmax and dP/dtmin responses maintained an additive interaction
upon coactivation on the two reflexes.

Therefore, the interaction between muscle

metaboreflex and arterial baroreflex when activated simultaneously in HF is occlusive
and the responses are significantly depressed compared to normal.
Regulation of skeletal muscle blood flow
Baroreceptor unloading during muscle metaboreflex activation in healthy subjects
causes vasoconstriction in all vascular beds including the ischemic hindlimb vasculature
but preferential vasoconstriction of the non-ischemic vasculature redistributes CO
towards the ischemic active muscle increasing HLBF. This increase in HLBF attenuates
muscle metaboreflex activation.

After induction of HF, BCO during metaboreflex

activation increases MAP via peripheral vasoconstriction, including vasoconstriction of
the ischemic skeletal muscle.

In contrast to normal animals, there is a very small

restoration of HLBF with coactivation of both reflexes in HF. Smaller vasoconstriction of
ischemic active muscle in normal animals could be a result of functional sympatholysis;
attenuated

sympathetic

vasoconstriction

of

active

muscle

due

to

metabolic

accumulation in the muscle (63). Since functional sympatholysis is impaired in HF (85),
the unopposed sympathetic vasoconstriction in the ischemic vascular bed prevents any
significant increase in HLBF in HF.
Perspectives and significance
In normal individuals, the arterial baroreflex buffers about one-half of the
metaboreflex-induced pressor response by attenuating peripheral vasoconstriction (40).
In heart failure, mechanisms of muscle metaboreflex activation switch from CO-
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mediated to peripheral vasoconstriction-mediated pressor response (29, 51, 81).
Impaired baroreflex buffering of the metaboreflex in HF would markedly increase
sympathetic vasoconstriction of all vascular beds, especially to the active ischemic
muscle.
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Stimulation of skeletal muscle afferents by metabolites that accumulate in the
exercising muscle elicits a large pressor response, termed the muscle metaboreflex.
Muscle metaboreflex activation during submaximal exercise induces large increases in
arterial pressure, cardiac output, heart rate and ventricular contractility however, the
vascular responses have varied in previous studies.

We addressed three specific

questions: 1) what are the mechanism(s) regulating the non-ischemic vasculature
during muscle metaboreflex activation in normal subjects, 2) whether muscle
metaboreflex activation vasoconstricts the ischemic active muscle from which this reflex
originates and if this vasoconstriction is exaggerated in heart failure and 3) how do the
arterial baroreflex and muscle metaboreflex interact with each other when activated
simultaneously in normal and heart failure animals.

Using chronically instrumented

canine model, data was collected before and after the induction of heart failure. We
found that: 1) muscle metaboreflex activation induces epinephrine release causing β2mediated vasodilation in skeletal muscle, 2) muscle metaboreflex activation elicits
vasoconstriction of ischemic active muscle which is exaggerated after induction of heart
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failure and 3) interaction between baroreflex and muscle metaboreflex in normal
animals depends on the parameter being investigated; however in heart failure, most
cardiovascular variables exhibit occlusive interactions. Preferential vasoconstriction of
non-ischemic vasculature redirects cardiac output and increases hindlimb blood flow in
normal animals but this increase is significantly attenuated in heart failure.

The

exaggerated vasoconstriction and limited increase in blood flow to the ischemic muscle
would impair the ability to exercise and contribute to exercise intolerance in heart failure
patients.
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